Poster Presentations Jerusalem

Tuesday September 27, 2016

CNS and its Barriers: the “Privilege” to be “Isolated”?

 18 – The Hippocampus is a (partially) immune privileged site
Nina Fainstein – Tamir Ben-Hur
Hadassah Hebrew University Medical Center, Dept. Of Neurology, Jerusalem, Israel

33 – The choroid plexus in psychological stress response
Alexander Kertser – Kuti Baruch – Michal Schwartz
Department Of Neurobiology, Weizmann Institute Of Science, Rehovot, Israel

41 – The novel role of activated leukocyte cell adhesion molecule (ALCAM) in neuroinflammation
Marc-André Lécuyer – Lyne Bourbonnière – Sandra Larouche – Laure Michel – Catherine Larochelle – Marc Charabati – Camille Pittet – Soufiane Ghannam – Alexandre Prat Université De Montréal, Centre De Recherche Du Chum (crchum), Montreal, Canada

92 – Poly(ADP-ribose) type 1 (PARP) inhibition in leukocytes diminishes inflammation via effects on integrins/cytoskeleton and protects the blood brain barrier (BBB)
Yuri Persidsky (1) – Viviana Zuluaga-Ramirez (1) – Nancy Reichenbach (1) – Holly Dykstra (1) – Sachin Gajghate (1) – Pal Pacher (2) – Slava Rom (1)
Lewis Katz School Of Medicine At Temple University, Pathology And Laboratory Medicine, Philadelphia, United States (1) – Nih, Niaaa, Bethesda, United States (2) 

135 – Blood brain barrier shielding and anti-inflammatory properties of cannabinoid type 2 receptor (CB2) agonists: Novel approach to treatment of neuroinflammation
Yuri Persidsky – Viviana Zuluaga-Ramirez – Nancy Reichenbach – Holly Dykstra – Servio Ramirez – Slava Rom
Lewis Katz School Of Medicine At Temple University, Pathology And Laboratory Medicine, Philadelphia, United States

198 – CNS endothelial IL-1 signaling drives neuroinflammation
Judith Hauptmann – Tommy Regen – Ari Waisman
Institute For Molecular Medicine, University Medical Center Of The Johannes Gutenberg University, Mainz, Germany

209 – Integrin alpha8 promotes T lymphocyte migration across the blood-CNS barriers
Elizabeth Gowing (1) – Steve Gendron (1) – Bieke Broux (2) – Marc-André Lécuyer (1) – Marc Charabati (1) – Evelyn Peelen (1) – Lyne Bourbonniere (1) – Sandra Larouche (1) – Simone Terouz (1) – Pierre Duquette (3) – Alexandre Prat (1)
Centre de recherche du CHUM, Université de Montréal, Montreal, Canada (1) – Biomed, Hasselt University, Hasselt, Belgium (2) – Clinique de Sclerose en Plaques, L’Hopital Notre Dame (CHUM), Montreal, Canada (3) 

247 – The Choroid Plexus as an Immunological Niche for CD4 T Cell-Mediated Immunity in the CNS
Itai Strominger – Omer Berner – Kritika Mittal – Nitzan Levy – Anna Nemirovsky – Alon Monsonego
Ben-Gurion University Of The Negev, Shraga Segal Department Of Microbiology, Immunology, And Genetics. National Institute Of Biotechnology In The Negev, Beer Sheva, Israel 

260 – Netrin-4 Promotes Neuroinflammation by Regulating the Blood-Brain Barrier
Marc Charabati (1) – Cornelia Podjaski (1) – Jean-Philippe Ouimet (1) – Marc-André Lécuyer (1) – Catherine Larochelle (1) – Jorge Ivan Alvarez (2) – Lyne Bourbonnière (1) – Sandra Larouche (1) – Nathalie Arbour (1) – Alexandre Prat (1)
Centre De Recherche Du Centre Hospitalier De L’université De Montréal (crchum), Université De Montréal, Montreal, Canada (1) – Department Of Pathobiology, School Of Veterinary Medicine, University Of Pennsylvania, Philadelphia, United States (2) 

263 – The Contribution of MCAM on the Blood-Brain Barrier to Neuroinflammation
Marc Charabati – Marc-André Lécuyer – Catherine Larochelle – Evelyn Peelen – Laure Michel – Lyne Bourbonnière – Sandra Larouche – Nathalie Arbour – Alexandre Prat
Centre De Recherche Du Centre Hospitalier De L’université De Montréal (crchum), Université De Montréal, Montreal, Canada

261 – KCNK2 regulates immune-cell trafficking into the CNS via the formation of nanoscale immune docking structures on brain endothelial cells
Tobias Ruck (1) – Stefanie Bock (1) – Jonas Franz (2) – Christoph Riethmüller (2) – Stefan Bittner (3) – Sven Meuth (1)
University Of Muenster, Department Of Neurology, Muenster, Germany (1) – Nanostic Institute, Centre For Nanotechnology, Muenster, Germany (2) – University Medical Center Of The Johannes Gutenberg University Mainz, Department Of Neurology, Mainz, Germany. (3) 

286 – let-7 microRNAs protect blood brain barrier (BBB) in ischemia/reperfusion
Slava Rom – Viviana Zuluaga-Ramirez – Sachin Gaghate – Nancy Reichenbach – Yuri Persidsky
Temple University School Of Medicine, Pathology And Laboratory Medicine, Philadelphia, United States

290 – Antigen expression by endothelial cells of the blood brain barrier elicits migration of CD8 T cells in the central nervous system
Céline Meyer (1) – Lidia Yshii (1) – Christina Gebauer (1) – Britta Engelhardt (2) – Roland Liblau (1) – Guillaume Martin-Blondel (3)
Centre De Physiopathologie De Toulouse Purpan (CPTP), Université Toulouse III, Toulouse, France (1) – Theodor Kocher Institute, University Of Bern, Bern, Switzerland (2) – Centre De Physiopathologie De Toulouse Purpan (CPTP)/department Of Infectious And Tropical Diseases, Toulouse University Hospital, Université Toulouse III, Toulouse, France (3) 

368 – The effect of liquid aspirin in an experimental model of systemic infection and neuroinflammation
Jessica Teeling (1) – James Stuart (2) – Jan Cohen (2) – Simon Cohen (2)
University Of Southampton, Biological Sciences, Southampton, United Kingdom (1) – Innovate Pharmaceuticals Limited, -, Bury, United Kingdom (2) 

383 – Single nucleus RNA-Seq reveals dynamics of adult newborn neurons
Naomi Habib (1,2,3*) – Yinqing Li (1,2,3,4*) – Matthias Heidenreich (1,2,3) – Lukasz Swiech (1,2,3) Inbal Avraham-Davidi (1) – John J. Trombetta (1) – Cynthia Hession (1) – Feng Zhang (1,2,3,5,6†) – Aviv Regev (1,7†)
Broad Institute of MIT and Harvard (1) – Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard (2) – McGovern Institute of Brain Research (3) – Department of Electrical Engineering and Computer Science (4) – Department of Brain and Cognitive Sciences (5) – Department of Biological Engineering (6) – Howard Hughes Medical Institute, Koch Institute of Integrative Cancer Research, Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts, USA (7) 

Gender and Ageing: Effects on the Immune System and Brain Plasticity

 50 – AGING AND RECURRENT EPISODES OF NEUROINFLAMMATION PROMOTES PROGRESSIVE EAE IN BIOZZI ABH MICE
Sandra Amor (1) – Laura Peferoen (1) – Marjolein Breur (1) – Sarah Van De Berg (1) – Regina Peferoen-Baert (1) – Erik Boddeke (2) – Paul Van Der Valk (1) – Gareth Pryce (3) – Johannes Van Noort (4) – David Baker (3)
Pathology Department, Vu University Medical Centre, Amsterdam, Netherlands (1) – Ugmc, Ugmc, Groningen, Netherlands (2) – Blizard, Qmul, London, United Kingdom (3) – Delta Crystallon Bv, Delta Crystallon Bv, Leiden, Netherlands (4) 

178 – Old mice accumulate effector CD4 T cells refractory to Treg-induced immunosuppression
Idan Harpaz – Udayan Bhattacharya – Nitzan Levy – Alon Monsonego
Ben-gurion University Of The Negev, The Shraga Segal Department Of Microbiology, Immunology And Genetics, Faculty Of Health Sciences, Beer Sheva, Israel

331 – Age-associated alterations of antioxidant status, calcium homeostasis and glucose transporter in aging female rat : Protective role of 17β estradiol
Pardeep Kumar – N Baquer
Jawaharlal Nehru University, School Of Life Sciences, New Delhi, India

362 – Inhibiting solTNF is Therapeutic for Neuropathic Pain in Male but not Female Mice
Tania Del Rivero – Kayla Murphy – John R. Bethea
Drexel University, Department Of Biology, Philadelphia, United States 

Lessons from Animal Models and Implications in the Pathogenesis of Human Neuroinflammatory Diseases

 6 – Development of a Mouse Model mimicking Paraneoplastic Neurological Disease
Christina Gebauer (1) – Beatrice Pignolet (1)Lidia Yshii (1) – Jan Bauer (2) – Emilie Mauré (1) – Roland Liblau (1)
Inserm U1043, Cptp, Chu Purpan, Toulouse, France (1) – Center Of Brain Research, Medical University Of Vienna, Vienna, Austria (2) 

7 – CTLA-4 blockade elicits paraneoplastic neurological disease in a mouse model
Lidia Yshii (1) – Christina Gebauer (1) – Béatrice Pignolet (1) – Emilie Mauré (1) – Clémence Quériault (1) – Mandy Pierau (2) – Hiromitsu Saito (3) – Noboru Suzuki (3) – Monika Brunner-Weinzierl (2) – Jan Bauer (4) – Roland Liblau (1)
Inserm Centre De Physiopathologie Toulouse-purpan U1043, Université De Toulouse, Toulouse, France (1) – Otto-von-guericke University Magdeburg, Department Of Experimental Pediatrics, University Hospital, Magdeburg, Germany (2) – Mie University Life Science Research Center, Department Of Animal Genomics, Functional Genomics Institute, Tsu, Japan (3) – Medical University Of Vienna, Center For Brain Research, Vienna, Austria (4) 

16 – TLR2 and TLR4 selectively regulate susceptibility of P0106-125-induced murine experimental autoimmune neuritis
Anna Brunn (1) – Mirna Mihelcic (1) – Mariana Carstov (1) – Lisa Feind (1) – Eva C. Wieser (1) – Julia Schmidt (1) – Olaf Utermöhlen (2, 3) – Martina Deckert (1)
Department of Neuropathology, University Hospital of Cologne, Cologne, Germany (1) – Institute for Medical Microbiology, Immunology and Hygiene, Medical Center, University of Cologne, Germany (2) – Center for Molecular Medicine, Cologne, Germany (3) 

29 – Alpha7 nicotinic acetylcholine receptor and RIC-3 in the cholinergic anti-inflammatory pathway and neuroinflammation
Yael Ben-David (1) – Tehila Mizrachi (2) – Karen Brusin (2) – Abhijit Kulkarni (3) – Ganesh Thakur (3) – Talma Brenner (2) – Millet Treinin (1)
The Hebrew University, Dept. Of Med. Neurobio., Jerusalem, Israel (1) – Hadassah Medical Center, Neurology, Jerusalem, Israel (2) – Pharmaceutical Sciences, School Of Pharmacy, Northeastern University, Boston, United States (3) 

31 – Caspr2-reactive antibody cloned from a mother of an ASD child mediates an ASD-like phenotype in mice
Lior Brimberg – Simone Mader – Venkatesh Jeganathan – Roseann Berlin – Thomas R. Coleman – Peter K. Gregersen – Patricio Huerta – Bruce T. Volpe – Betty Diamond
The Feinstein Institute For Medical Research, North Shore Hospital, Manhasset, United States 

54 – The death receptor Fas promotes Th17 cell function by inhibiting STAT1 activation
Gerd Meyer Zu Horste (1) – Dariusz Przybylski (2) – Chao Wang (1) – Alexandra Schnell (1) – Youjin Lee (1) – Aviv Regev (2) – Vijay Kuchroo (1)
Harvard Medical School And Brigham And Women’s Hospital, Evergrande Center For Immunologic Diseases, Boston, Ma, United States (1) – The Broad Institute, Mit And Harvard, Cambridge, Ma, United States (2) 

61 – Pain behaviours and neuroinflammation in experimental autoimmune encephalomyelitis
Samuel Duffy (1) – Chamini Perera (1) – Preet Makker (1) – Justin Lees (1) – Pascal Carrive (2)Gila Moalem-Taylor (1)
University Of New South Wales, School Of Medical Sciences, Department Of Physiology, Sydney, Australia (1) – University Of New South Wales, School Of Medical Sciences, Department Of Anatomy, Sydney, Australia (2) 

88 – Myelin Damage and Repair in an Antibody Model of Multiple Sclerosis Demyelination
Yiting Liu (1) – Katherine Saul (2) – Danielle Harlow (2) – Adeline Matschulat (1) – Gregory Owens (1) – Wendy Macklin (2) – Jeffrey Bennett (1)
University Of Colorado, Anschutz Medical Campus, Neurology, Aurora, CO, United States (1) – University Of Colorado, Anschutz Medical Campus, Cell & Developmental Biology, Aurora, CO, United States (2) 

139 – Toll-like receptors are not required for induction of Experimental Autoimmune Encephalomyelitis in mice
Filipa Marques Ferreira – Pushpalatha Palle – Thorsten Buch
University Of Zurich, Institute Of Laboratory Animal Sciences, Zurich, Switzerland

149 – Extraocular inflammation in experimental neuromyelitis optica
Kaufmann Nathalie (1) – Bleranda Zeka (1) – Maria Hastermann (1) – Tatsuro Misu (2) – Paulus Rommer (3) – Kazuo Fujihara (2) – Zsolt Illes (4) – Charlotte Dahle (5) – Fritz Leutmezer (3) – Markus Reindl (6) – Hans Lassmann (1) – Monika Bradl (1)
Department For Neuroimmunology, Center For Brain Research, Medical University Vienna, Vienna, Austria (1) – Department Of Neurology, Tohoku University Graduate School Of Medicine, Sendai, Japan (2) – Department Of Neurology, Medical University Vienna, Vienna, Austria (3) – Department Of Neurology, University Of Southern Denmark, Odense, Denmark (4) – Department Of Clinical And Experimental Medicine (ike), Division Of Neuro And Inflammation Sciences, Linköping University, Linköping, Sweden (5) – Clinical Department For Neurology, Medical University Of Innsbruck, Innsbruck, Austria (6) 

161 – Antibody in cerebrospinal fluid can be directed to specific sites in brain
Marlene Thorsen Mørch – Reza Khorooshi – Nasrin Asgari – Trevor Owens
Institute Of Molecular Medicine, Department Of Neurobiology, University Of Southern Denmark, Odense, Denmark

166 – Retinal inflammation in Neuromyelitis optica: primary axonal dysfunction/damage and loss of aquaporin-4
Bleranda Zeka (1) – Maria Hastermann (1) – Nathalie Kaufmann (1) – Kathrin Schanda (2) – Marko Pende (3) – Tatsuro Misu (4) – Paulus Rommer (5) – Kazuo Fujihara (4) – Charlotte Dahle (6) – Fritz Leutmezer (5) – Markus Reindl (2) – Hans Lassmann (1) – Monika Bradl (1) Medical University Of Vienna, Department Of Neuroimmunology, Center For Brain Research, Vienna, Australia (1) – Innsbruck Medical University, Clinical Department Of Neurology, Austria, Innsbruck, Austria (2) – Medical University Of Vienna, Section For Bioelectronics, Center For Brain Research, Vienna, Austria (3) – Tohoku University Graduate School Of Medicine, Department Of Neurology, Sendai, Japan (4) – Medical University Vienna, University Hospital For Neurology, Vienna, Austria (5) – Linköping University, Department Of Clinical And Experimental Medicine, Faculty Of Health Sciences, Linköping, – (6) 

177 – Ocytes in Alzheimer’s disease: role of protein kinase C
Amitha Muraleedharan – Noa Rotem-Dai – Etta Livneh – Alon Monsonego
The Shraga Segal Department of Microbiology and Immunology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer Sheva, Israel-84105

214 – Depletion of CD52+ cells inhibits the development autoimmune encephalomyelitis, but can block the induction of immunological tolerance: Implications for drug-induced secondary autoimmunity in MS
Stephanie Von Kutzleben – Gareth Pryce – Gavin Giovannoni – Klaus Schmierer – David Baker
Blizard Institute, Queen Mary University Of London, London, United Kingdom

215 – Autoantibody mediated T cell activation within the nervous tissue triggers CNS autoimmunity
Fred Lühder – Anne-Christine Flach – Tanja Litke – Judith Strauss – Francesca Odoardi – Alexander Flügel
Institute for Multiple Sclerosis Research and Neuroimmunology, University of Göttingen Medical Center, Göttingen, Germany

223 – The leptomeninges: a checkpoint to control T cell trafficking and function in the course of CNS autoimmunity
Dmitri Lodygin – Christian Schläger – Henrike Körner – Francesca Odoardi – Alexander Flügel
Institute For Multiple Sclerosis Research And Neuroimmunology, University Of Göttingen, Göttingen, Germany

252 – Epilepsy and Microglial Dysregulation in CD39 Deficient Mice
Amanda Lanser (1) – Rafael Rezende (1) – Paul Lorello (1) – Huixin Xu (1) – Lauren Anderson (2) – Chris Dulla (2) – Barbara Caldarone (1) – Harvard Weiner (1)
Harvard, Bwh, Boston, United States (1) – Tufts University, Tufts University, Boston, United States (2) 

270 – Long-term cognitive decline and synaptic dysfunction due to severe pneumonia-induced neuroinflammation
Flora Oliveira (1) – Tatiana Maron-Gutierrez (1) – Bruno Bergamini (2) – Alysson Roncally (2) – Patrícia Reis (1) – Patrícia Bozza (1) – Hugo Castro-Faria-Neto (1) – Fernando Bozza (1) Fundação Oswaldo Cruz, Immunopharmacology, Rio De Janeiro, Brazil (1) – Federal University Of Rio De Janeiro, Respiratory Physiology, Rio De Janeiro, Brazil (2) 

283 – Rosiglitazone role in sepsis encephalopathy of pneumonia origins
Gabriel Gutfilen Schlesinger – Cassiano Felippe Gonçalves De Albuquerque – Patricia Alves Reis – Fernando Augusto Bozza – Adriana Ribeiro Silva
Fiocruz, Oswaldo Cruz Institute, Rio De Janeiro, Brazil

284 – Contactin-2/TAG-1 role in myelination and demyelination
Domna Karagogeos – Maria Savvaki – Lida Zoupi – Katerina Kalemaki – Ilias Kalafatakis Medical School, University of Crete and IMBB-FORTH, Heraklion, Greece

285 – Novel microneurotrophins contribute to oligodendrocytes survival and proliferation in the cuprizone model of de- and remyelination
Giulia Bonetto (1) – Ioannis Charalampopoulos (2) – Achilleas Gravanis (2)Domna Karagogeos (1)
Medical School, University Of Crete And Imbb Forth, Neuroscience, Heraklion, Greece (1) – Medical School, University Of Crete And Imbb Forth, Pharmacology, Heraklion, Greece (2) 

338 – Addressing pivotal challenges in applied neuroscience: a knowledge center for research on brain diseases
Hanna Rosenmann (1) – Tamir Ben-Hur (1) – Bernard Lerer (2)
Neurology, Hadassah – Hebrew University Medical Center, Jerusalem, Israel (1) – Psychiatry, Hadassah – Hebrew University Medical Center, Jerusalem, Israel (2) 

342 – Long lasting effect of mesenchymal stem cells treatment in BTBR autism model
Nisim Perets
Felsenstein Research Medical Center, Beilinson Hospital, Petah Tikva, Israel

343 – Introduction of anti-inflammatory and glutamate uptake genes reduces the neuronal damage in mouse model of focal ischemia
Ariel Angel – Lior Molcho – Tali Ben-Tzur – Yael Barhum – Adi Egozi – Daniel Offen Felsenstein Research Medical Center, Tel Aviv University, Petah Tikva, Israel

344 – Altered astrocytic response to activation in SOD1(G93A) mice and its implications on amyotrophic lateral sclerosis pathogenesis
Chen Bankler – Tali Ben-Tzur – Yael Barhum – Daniel Offen
Felsenstein Research Medical Center, Tel Aviv University, Petah Tikva, Israel

351 – History doesn’t repeat but it rhymes: Lessons from Spanish Flu virulence determinants
Alex Silaghi (1) – Gary Kobinger (2) – Darwyn Kobasa (3)
University Of Manitoba, Depts Of Internal Medicine-section Of Neurology; Medical Microbiology, Winnipeg, Canada (1) – Public Health Agency Of Canada; University Of Manitoba, Phac-special Pathogens (phac); Dept Of Medical Microbiology, Winnipeg, Canada (2) – Public Health Agency Of Canada (phac); University Of Manitoba, Phac-special Pathogens; Dept Of Medical Microbiology, Winnipeg, Canada (3) 

352 – Immunization against MIP3α may confer protection against multiple sclerosis
Michal Abraham (2)Arnon Karni (3) – Amnon Peled (1, 2)
Goldyne Savad Institute of Gene Therapy, Hebrew University Hospital, Jerusalem, Israel (1) – Biokine Therapeutics Ltd, Ness Ziona, Israel (2) – Neuroimmunology Laboratory, Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv University, Tel Aviv, Israel (3) 

359 – Cross tolerance: Embryonic heat conditioning induces immune tolerance
Tali Rosenberg (1, 2) – Tatiana Kisliouk (2) – Noam Meiri (2)
The Robert H. Smith Faculty of Agriculture, Food and Environment, the Hebrew University of Jerusalem, Rehovot, Israel (1) – Institute of Animal Science, ARO, The Volcani Center, Bet Dagan, Israel (2) 

366 – The function of pain associated fibers in MOG induced EAE
Isaac Levi (1) – Lena Finkelshtein (1) – Hagar Sonego (1) – Ayelet Weksler (1) – Ilana Tsetsarsky (1) – David Castel (2) – Sigal Meilin (1)
Md Biosciences Innovalora, Neuroscience, Ness Ziona, Israel (1) – Sheba Medical Cener, Tel Aviv U., Tel Aviv, Israel (2) 

369 – Pharmacologically inhibiting soluble TNFa signaling mitigates autonomic dysreflexia after complete high thoracic spinal cord injury
Eugene Mironets (1) – Shaoping Hou (1) – John Bethea (2) – Patrick Osei-Owusu (3) – Veronica Tom (1)
Drexel University College Of Medicine, Neuroscience, Philadelphia, United States (1) – Drexel University, Biology, Philadelphia, United States (2) – Drexel University College Of Medicine, Pharmacology And Physiology, Philadelphia, United States (3) 

370 – Brain inflammation and cognitive impairment in WT mice mediated by C1 inhibitor
Dorit Farfara – Emily Feierman – Erin Norris – Sidney Strickland
The Rockefeller University, Neurobiology & Genetics, Ny, United States 

MS Immunotherapy: Old and New Players (from the bench to bedside)

 76 – Fingolimod effects on monocyte microvesicle shedding in Multiple Sclerosis
Antonella Amoruso  – Maria Blonda – Roberta Grasso – Valeria Di Francescantonio – Carlo Avolio
Dept. Of Medical And Surgical Sciences, University Of Foggia, Foggia, Italy

77 – Multiple Sclerosis treatments affect monocyte derived microvesicle production
Maria Blonda – Antonella Amoruso – Roberta Grasso – Valeria Di Francescantonio – Carlo Avolio
University Of Foggia, Dep. Of Medical And Surgical Sciences, Foggia, Italy

82 – Involvement of HCAR2-triggered pathways in dimethyl fumarate effect on immune and other cells
Benedetta Parodi – Nicole Kerlero De Rosbo – Antonio Uccelli
Neuroimmunology Unit – Department Of Neuroscience, University Of Genoa, Genoa, Italy

160 – Haematopoietic stem cell transplantation for relapsing remitting multiple sclerosis. Long-term follow-up data from two Swedish centra
Andreas Tolf (1) – Sara Nilsson (2) – Ellen Iacobaeus (3) – Fredrik Piehl (3) – Hans Hägglund (4) – Kristina Carlson (4) – Joachim Burman (5)
Department Of Neuroscience, Uppsala University, Uppsala, Sweden (1) – Faculty Of Medicine, Uppsala University, Uppsala, Sweden (2) – Department Of Neurology, Karolinska University Hospital, Stockholm, Sweden (3) – Division Of Hematology, Department Of Medical Science, Uppsala University Hospital, Uppsala, Sweden (4) – Department Of Neurology, Uppsala University Hospital, Uppsala, Sweden (5) 

180 – Teriflunomide: immunomodulatory effect on adaptive and innate immune cell subsets
Ilaria Gandoglia (1) – Federico Ivaldi (1) – Federica Benvenuto (1) – Alice Laroni (1) – Nicole Kerlero De Rosbo (1) – Claudio Solaro (2) – Antonio Uccelli (1)
Department Of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal And Child Health (dinogmi),, University Of Genoa, Genoa, Italy (1) – Asl3 Liguria, Padre Antero Micone Hospital, Genoa, Italy (2) 

190 – Reduced adhesion to human endothelium as one mechanism of action of dimethyl fumarate in Multiple Sclerosis
Johanna Breuer (1) – Sebastian Herich (1) – Tilman Schneider-Hohendorf (1) – Nina Wettschureck (2) – Luisa Klotz (1) – Heinz Wiendl (1) – Nicholas Schwab (1)
University Of Muenster, Neurology, Muenster, Germany (1) – University Of Frankfurt, Molecular Pharmacology, Frankfurt, Germany (2) 

194 – Lymphocyte dynamics and (auto) immunity in multiple sclerosis induction treatment: Clues from phase III trial data of Cladribine compared to Alemtuzumab
Klaus Schmierer (1, 2) – Samuel Spencer Herrod (1) – Cesar Alvarez-Gonzalez (1) – Monica Marta (1, 2) – David Baker (1)
Queen Mary University Of London, Blizard Institute (Neuroscience), London, United Kingdom (1) – Barts Health NHS Trust, The Royal London Hospital, ECAM Clinical Academic Group Neuroscience, London, United Kingdom (2) 

216 – Characterizing the Impact of Teriflunomide on the CD4+ T-Cell Repertoire of Patients With Relapsing-Remitting Multiple Sclerosis in the Teri-DYNAMIC Study
Heinz Wiendl (1) – Catharina C Gross (1) – Maren Lindner (1) – Melanie Eschborn (1) – Linda Weisser (1) – Anita Posevitz-Fejfar (1) – Andreas Schulte-Mecklenbeck (1) – Bart Van Wijmeersch (2) – Sandrine Brette (3) – Timothy J Turner (4) – Alexandre Jagerschmidt (5) – Amit Bar-Or (6) – Raymond Hupperts (7) – Luisa Klotz (1)
University Of Münster, Department Of Neurology, Münster, Germany (1) – Hasselt University, Department Of Immunology, Hasselt, Belgium (2) – Lincoln, Biostatistics, Boulogne-billancourt, France (3) – Sanofi Genzyme, Translational Medicine, Cambridge, United States (4) – Sanofi Genzyme, Clinical & Translational Biomarkers, Chilly-mazarin, France (5) – Montreal Neurological Institute, Department Of Neurology And Neurosurgery, Montreal, Canada (6) – Maastricht University, Orbis Medical Center, Maastricht, Netherlands (7) 

256 – A novel role of TCF-1 in regulating T cell effector function in Multiple Sclerosis
Radhika Raheja (1) – Maria Antonietta Mazzola (1) – Murugaiyan Gopal (1) – Hasan Rajabi (2) – Thomas Pertel (1) – Keren Regev (1) – Russell Griffin (1) – Pia Kivisakk (1) – Parham Nejad (1) – Bonnie Glanz (3) – Tanuja Chitnis (3) – Howard Weiner (1) – Roopali Gandhi (1)
Harvard Medical School, Brigham And Women’s Hospital, Boston, United States (1) – Dana Farber Cancer Institute, Harvard Medical School, Boston, United States (2) – Partners Ms Center, Brigham And Women’s Hospital, Boston, United States (3) 

340 – Effect of dimethyl fumarate treatment on T lymphocytes and antigen presenting cells in multiple sclerosis patients
Maria Antonietta Mazzola – Radhika Raheja – Keren Regev – Anu Paul – Isabelle Pierre – Pia Kivisakk – Howard Weiner – Roopali Gandhi
Brigham And Women’s Hospital And Harvard Medical School, Ann Romney Center For Neurological Disease, Boston, Ma, United States 

279 – Microglial microvesicles as therapeutic vector for neuroinflammation Giacomo Casella (1) – Federico Colombo (1) – Annamaria Finardi (2) – Roberto Furlan (2) Università Vita-Salute San Raffaele, Milan, Italy (1) – Ospedale San Raffaele, Clinical Neuroimmunology, Milan, Italy (2) 

298 – aHSCT greatly reduces axonal loss in MS as evidenced by a reduction in the levels of CSF neurofilaments
Jennifer Black (1) – Douglas Arnold (2) – Jaqueline Chen (2) – Marjorie Bowman (3) – Harold Atkins (4)Mark Freedman (3)
University Of Ottawa, Biochemistry, Microbiology & Immunology, Ottawa, Canada (1) – Montreal Neurological Institute And Hospital, Neurology And Neurosurgery, Montreal, Canada (2) – Ottawa Hospital Research Institute, Neuroscience Program, Ottawa, Canada (3) – Ottawa Hospital Research Institute, Cancer Therapeutics Program, Ottawa, Canada (4) 

303 – mRNA electroporation is an effective tool to induce long-term myelin expression by human tolerogenic dendritic cells
Judith Derdelinckx (1, 2) – Wai-Ping Lee (1) – Maxime De Laere (1) – Patrick Cras (2) – Barbara Willekens (2) – Zwi N. Berneman (1, 3) – Nathalie Cools (1)
Laboratory Of Experimental Hematology, Vaccine And Infectious Disease Institute (vaxinfectio), Faculty Of Medicine And Health Sciences, University Of Antwerp, Edegem, Belgium (1) – Antwerp University Hospital, Division Of Neurology, Edegem, Belgium (2) – Antwerp University Hospital, Center For Cell Therapy And Regenerative Medicine, Edegem, Belgium (3) 

318 – Increased Expression of miR-130b-5p in B cells and its Modulation by Glatiramer Acetate in Multiple Sclerosis
Latt Latt Aung- Suhayl Dhib-Jalbut- Konstantin Balashov
Department of Neurology, Rutgers-Robert Wood Johnson Medical School, New Brunswick, NJ, United States

327 – A tolerogenic dendritic cell-based therapy for the treatment of multiple sclerosis: a first-in-human clinical trial
Nathalie Cools (1) – Wai-Ping Lee (1) – Maxime De Laere (1) – Barbara Willekens (2) – Judith Derdelinckx (1, 2) – Griet Nijs (3) – Patrick Cras (2) – Cristina Ramo Tello (4) – Eva Martinez-Caceres (4) – Zwi Berneman (1, 3)
University Of Antwerp, Laboratory Of Experimental Hematology, Antwerp, Belgium (1) – Antwerp University Hospital, Division Of Neurology, Antwerp, Belgium (2) – Antwerp University Hospital, Center For Cell Therapy And Regenerative Medicine, Antwerp, Belgium (3) – Universitat Autònoma Barcelona, German Trias I Pujol University Hospital, Badalona, Spain (4) 

329 – The Relationship between the clinical condition of Multiple sclerosis patients and the nutritional status, mitochondrial activity and oxidative stress
Ayelet Armon-Omer (1) – Chen Waldman A (1) – Radi Shahien (2)
Ziv Medical Center, Research Lab, Zefat, Israel (1) – Ziv Medical Center, Neurology Unit, Zefat, Israel (2) 

335 – Potential benefits of the anti-IL-6 receptor antibody tocilizumab in patients with multiple sclerosis and seronegative neuromyelitis optica spectrum disorders
Manabu Araki – Masakazu Nakamura – Wakiro Sato – Takashi Yamamura
National Center Of Neurology And Psychiatry, Multiple Sclerosis Center, Tokyo, Japan

363 – CTLA4 as Immunological Checkpoint in the Development of Multiple Sclerosis
Eduardo Beltrán (1) – Lisa A. Gerdes (1) – Kathrin Held (1) – Carola Berking (2) – Jörg C. Prinz (2) – Andreas Junker (3) – Julia K. Tietze (2) – Birgit Ertl-Wagner (4) – Andreas Straube (5) – Tania Kümpfel (1) – Klaus Dornmair (1) – Reinhard Hohlfeld (1)
Institute Of Clinical Neuroimmunology, Biomedical Center And University Hospital, Grosshadern-martinsried Campus, Ludwig Maximilian University, Munich, Germany (1) – Department Of Dermatology And Allergology, Ludwig Maximilian University, Munich, Germany (2) – Department Of Neuropathology, University Of Göttingen, Göttingen, Germany (3) – Department Of Radiology, Grosshadern Medical Campus, Ludwig Maximilian University, Munich, Germany (4) – Department Of Neurology, Ludwig Maximilian University, Munich, Germany (5) 

The Microbiome and External Infectious Challenges in Neuroimmunological Diseases

122 – Super-resolution microscopy and live-cell imaging to reveal probiotic-dendritic cell interaction
Elena Rinaldi (1) – Chiara Cordiglieri (1) – Alessandra Consonni (1) – Cristina Cappelletti (1) – Marina Elli (2) – Renato Mantegazza (1) – Fulvio Baggi (1)
Neurological Institute Carlo Besta, Department of Neurology IV, Milan, Italy (1) – Advanced Analytical Technologies, Fiorenzuola d’Arda (PC), Italy (2) 

225 – EBV infection affects the processing of myelin oligodendrocyte glycoprotein peptides in B cells – Implications for Multiple Sclerosis
Elena Morandi (1) – Anwar Jagessar (2)Cris Constantinescu (1) – Bert t` Hart (2) – Bruno Gran (1)
University Of Nottingham, Division Of Clinical Neuroscience, Clinical Neurology Research Group, Nottingham, United Kingdom (1) – Biomedical Primate Research Centre (bprc), Immunobiology Department, Rijswijk, Netherlands (2) 

242 – Cytomegalovirus infection exacerbates autoimmune mediated neuroinflammation
Marjan Vanheusden (1) – Bieke Broux (1) – Suzanne Welten (2) – Liesbet Peeters (1) – Bart Van Wijmeersch (1) – Veerle Somers (1) – Piet Stinissen (1) – Ramon Arens (2)Niels Hellings (1)
Hasselt University, Biomedical Research Institute, Diepenbeek, Belgium (1) – Leiden University Medical Center, Department Of Immunohematology And Blood Transfusion, Leiden, Netherlands (2) 

280 – The effect of early-life microbiota disruption on experimental autoimmune encephalomyelitis
Laura Cox – Chantal Kuhn – Stephanie Tankou – Howard Weiner
Brigham And Women’s Hospital/harvard Medical School, Neurology, Boston, United States

360 – Gut Microbiota from Multiple Sclerosis patients triggers autoimmune encephalomyelitis in mice
Kerstin Berer (1) – Lisa Ann Gerdes (2) – Egle Cekanaviciute (3) – Liang Xiao (4) – Zhongkui Xia (4) – Chuan Liu (4) – Uta Stauffer (5) – Sergio E. Baranzini (3) – Tania Kümpfel (2) – Reinhard Hohlfeld (2) – Gurumoorthy Krishnamoorthy (1) – Hartmut Wekerle (1)
Max Planck Institute of Neurobiology, Neuroimmunology, Munich, Germany (1) – Ludwig-Maximilians University, Institute of Clinical Neuroimmunology, Munich, Germany (2) – University of California, Department of Neurology, San Francisco, United States (3) – BGI-shenzhen, BGI Genomics, Shenzhen, China (4) – Max Planck Institute of Immunobiology and Epigenetics, Laboratory Animal Facility, Freiburg, Germany (5) 

Vaccines in Neuroimmunology

 4 – Chronic spinal cord injury attenuates influenza virus specific antiviral immunity
Valerie Bracchi-Ricard (1) – Ji Zha (1) – Samita Andreasky (2)John R. Bethea (1)
Drexel University Department Of Biology, University, Philadelphia, United States (1) – University Of Miami, University, Miami, United States (2) 

36 – ASSESSING THE EFFICACY OF A DNA VACCINE AGAINST AMYLOID-Β IN A DOWN-SYNDROME MOUSE MODEL
Eitan Okun (1) – Tomer Illouz (2)
The Leslie And Susan Gonda Multidisciplinary Brain Research Center, The Mina And Everard Goodman Faculty Of Life Sciences, Bar-ilan University, Ramat Gan, Israel (1) – The Leslie And Susan Gonda Multidisciplinary Brain Research Center, Bar-ilan University, Ramat Gan, Israel (2) 

350 – Assessing the efficacy of a DNA vaccine against Amyloid-beta in a Down-syndrome mouse model
Tomer Illouz – Eitan Okun
Bar-ilan University, The Leslie And Susan Gonda Multidisciplinary Brain Research Center, Ramat Gan, Israel

102 – Protective effects of a parasite-derived 68-mer peptide in a relapsing mouse model of multiple sclerosis
Judith Greer (1) – Aakanksha Dixit (1) – Sheila Donnelly (2)
The University Of Queensland, Uq Centre For Clinical Research, Brisbane, Australia (1) – University Of Technology Sydney, The School Of Life Sciences, Sydney, Australia (2) 

158 – Inverse vaccination with superior dominant peptide may eradicate multiple sclerosis via sequential induction of stabilized hybrid regulatory T cells with antigen specificity and tissue repair capacity
Youwei Lin (1,2) – Chandirasegaran Massilamany (3) – Jayagopala Reddy (3) – Takashi Yamamura (1)
Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP), Tokyo, JAPAN (1) – Department of Neurology, National Center Hospital, NCNP, Tokyo, JAPAN (2) – School of Veterinary Medicine and Biomedical Sciences, University of Nebraska-Lincoln, Lincoln, USA (3) 

377 – The impact of surgical stress, immune stimulation, and native immune cells on brain metastasis
Amit Benbenishty (1 ,2, 3) – Lee Shaashua (1) – Ariella Glasner (4) – Yosi Azan (1) – Shamgar Ben-Eliyahu (1, 3) – Pablo Blinder (2, 3)
School of Psychological Sciences, Tel Aviv University, Tel Aviv, 69978, Israel (1) – Neurobiology Dep., Tel Aviv University, Tel Aviv, 69978, Israel (2) – Sagol School of Neuroscience, Tel Aviv University, Tel Aviv, 69978, Israel (3) – The Lautenberg Centre for General and Tumor Immunology, The Hebrew University Hadassah, Jerusalem, 91120, Israel (4) 

"

Wednesday September 28, 2016

Autoimmune Channelopathies of the CNS

60 – Comparison of antibody assays in anti-NMDAR encephalitis
Matteo Gastaldi* (1,2) – Anaïs Thouin* (1,3) – Ester Coutinho (1) – Leslie Jacobson (1) – Sarosh Irani (1) – Diego Franciotta (4) – Angela Vincent (1)
University of Oxford, Oxford, UK (1) – University of Pavia, Pavia, Italy (2) – University if Newcastle upon Tyne, Newcastle, UK (3) – IRCCS Mondino, Pavia, Italy (4) 

85 – Pathological Mechanisms of Glycine Receptor Antibodies
Sarah J Crisp (1) – Angela Vincent (2) – John Rothwell (3) – Dimitri M Kullmann (1)
Institute Of Neurology, University College London, Department Of Clinical And Experimental Epilepsy, London, United Kingdom (1) – University Of Oxford, Nuffield Department Of Clinical Neurosciences, Oxford, United Kingdom (2) – Institute Of Neurology, University College London, Sobell Department Of Motor Neuroscience, London, United Kingdom (3) 

145 – Different Antibodies Production in Autoimmune Chanellopathies
Dmitriy Labunskiy
University of Northern California, Biomedical Engineering, Santa Rosa, CA, United States

162 – Pitfalls in Morvan’s Syndrome diagnosis: two atypical cases mimicking motor neuron disease
Michelangelo Cao (1) – Francesco Cavallieri (2) – Laura Mirandola (2) – Marco Zoccarato (3) – Elena Pegoraro (4) – Gianni Sorarù (4) – Jessica Mandrioli (2)
University Of Oxford, Nuffield Department Of Clinical Neurosciences, Oxford, United Kingdom (1) – Department Of Neuroscience, S. Agostino-estense Hospital, University Of Modena And Reggio Emilia, Modena, Italy (2) – U.O. Di Neurologia, Ospedale Regionale Di Treviso, Treviso, Italy (3) – Department Of Neurosciences, University Of Padova, Padova, Italy (4) 

186 – Effect of Maternal Antibodies Directed to the Astrocytic Water Channel Protein AQP4 in Neuromyeltis Optica Pregnancies
Simone Mader (1) – Lior Brimberg (2) – James M. Crawford (3) – Alexandre Bonnin (4) – Jeffrey L Bennett (5) – Patricio Huerta (1) – Bruce T Volpe (1) – Betty Diamond (1)
The Feinstein Institute For Medical Research, Center For Autoimmune And Musculoskeletal Diseases, Manhasset, United States (1) – The Feinstein Institute For Medical Research, Center For Autoimmune And Musculoskeletal Diseases, New York, United States (2) – Hofstra North Shore–lij School Of Medicine, Department Of Pathology And Laboratory Medicine, Hempstead, United States (3) – Zilkha Neurogenetic Institute And Department Of Cell And Neurobiology, Keck School Of Medicine Of The University Of Southern California, Los Angeles, United States (4) – University Of Colorado School Of Medicine, Department Of Neurology And Ophthalmology, Denver, United States (5) 

187 – Cerebrospinal Fluid Free Light Chain profile is different in the two main sub-types of Autoimmune Encephalitis
Keerthi Senthil (1) – Abid Karim (2) – Mark Drayson (2)Saiju Jacob (1)
Department Of Neurology And Neuroimmunology, University Hospitals Birmingham And University Of Birmingham, Birmingham, United Kingdom (1) – Department Of Neuroimmunology, University Of Birmingham, Birmingham, United Kingdom (2) 

192 – Review of GAD antibody assay in over 850 patients and analysis of clinical phenotype and response to immunotherapy in 15 Stiff Person Syndrome patients
Girija Sadalage (1) – Savinda Weerasinghe (1) – Abid Karim (2)Saiju Jacob (3)
Department Of Neurology, University Hospitals Birmingham, Birmingham, United Kingdom (1) – Department Of Neuroimmunology, University Of Birmingham, Birmingham, United Kingdom (2) – Department Of Neurology And Neuroimmunology, University Hospitals Birmingham And University Of Birmingham, Birmingham, United Kingdom (3) 

201 – Neuropathological Investigation of LGI1-Encephalitis in Cats
Anna Tröscher (1) – Maria French (1) – Andrea Klang (2) – Akos Pakozdy (3) – Jan Bauer (1)
Medical University Of Vienna, Department Of Neuroimmunology, Center For Brain Research, Vienna, Austria (1) – University Of Veterinary Medicine Vienna, Institute Of Pathology And Forensic Veterinary Medicine, Vienna, Austria (2) – University Of Veterinary Medicine Vienna, Clinic For Internal Medicine And Infectious Diseases, Vienna, Austria (3) 

255 – Investigations into the pathogenic properties of glycine receptor autoantibodies using transfected human embryonic kidney cells and zebrafish embryos
Niels Von Wardenburg (1) – Kazutoyo Ogino (2) – Hiromi Hirata (2) – Carmen Villmann (1)
Institute Of Clinical Neurobiology, University Hospital Of Würzburg, Würzburg, Germany (1) – Department Of Chemistry And Biological Science, Aoyama Gakuin University, Tokyo, Japan (2) 

Neuroinflammation Beyond Traditional Neuroimmune Diseases

13 – Bradykinin 1 receptor blockage increases amyloid beta burden and glial inflammation
Keren Asraf – Nofar Torika – Sigal Fleisher-Berkovich
Department of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences, Ben-Gurion University of the Negev, Beer-Sheva, Israel

32 – Non- invasive intranasal treatment of angiotensin related drugs as potential therapy for Alzheimer’s disease
Nofar Torika-Nadiv – Keren Asraf – Sigal Fleisher-Berkovich
Ben Gurion University Of The Negev, Department Of Clinical Biochemistry And Pharmacology, Beer-sheva, Israel

65 – Trem2 deficiency alters Alzheimer’s disease-like pathology in mice
Kelly R. Miller (1, 5)Pascale Eede (1) – K. Peter Nilsson (1, 4) – Frank L. Heppner (1, 2, 3)
Department of Neuropathology, Charité – Universitätsmedizin Berlin, Charitéplatz 1, 10117 Berlin, Germany (1) – Cluster of Excellence “NeuroCure,” 10117 Berlin, Germany (2) – Berlin Institute of Health (BIH), 10117 Berlin, Germany (3) – Departments of Physics, Chemistry and Biology (IFM), Linköping University, Linköping SE-581 83, Sweden (4) – Present address: Center for Neurodegenerative Disease Research, Perelman School of Medicine, University of Pennsylvania, Philadelphia PA 19104, United States (5) 

71 – Antibodies against human hypocretin receptor 2 are rare in idiopathic narcolepsy
Maria Pia Giannoccaro (1) – Patrick Waters (1) – Fabio Pizza (2) – Rocco Liguori (2) – Giuseppe Plazzi (2)Angela Vincent (1)
Nuffield Department Of Clinical Neurosciences, Oxford University, Oxford, United Kingdom (1) – Irccs Institute Of The Neurological Sciences Of Bologna, Bellaria Hospital, Bologna, Italy (2) 

80 – microRNA-146a has therapeutic effects in seizure and epilepsy models by reducing the IL-1R1/TLR4 signaling activation in neurons and glia
Valentina Iori (1) – Anand Iyer (2) – Luca Beltrame (3) – Lara Paracchini (3) – Sergio Marchini (3) – Milica Cerovic (1) – Teresa Ravizza (1) – Riccardo Brambilla (4) – Maurizio D’Incalci (3) – Eleonora Aronica (2) – Annamaria Vezzani (1)
Mario Negri Institute For Pharmacological Research, Neuroscience, Milan, Italy (1) – Academisch Medisch Centrum, Neuropathology, Amsterdam, Netherlands (2) – Mario Negri Institute For Pharmacological Research, Oncology, Milan, Italy (3) – San Raffaele Institute, Neuroscience, Milan, Italy (4) 

83 – Reduction of Cytosolic Phospholipase A2alpha upregulation in the spinal cord delays onset of symptoms in the SOD1-G93A mouse model of Amyotrophic Lateral Sclerosis
Rachel Levy – Yulia Solomonov – Nurit Hadad
Ben Gurion University of The Negev and Soroka University Medical Center, Clinical Biochemistry and Pharmacology, Beer-Sheva, Israel

84 – Identification of antibodies against inositol 1,4,5-triphosphate receptor 1 in cerebellar disorders
Pinelopi Fouka (1) – Harry Alexopoulos (1) – Ioanna Chatzi (1) – Scarlatos Dedos (2) – Martina Samiotaki (3) – George Panayotou (3) – Panagiotis Politis (4) – Athanasios Tzioufas (5) – Marinos Dalakas (1)
Faculty Of Medicine, University Of Athens, Neuroimmunology Unit, Department Of Pathophysiology, Athens, Greece (1) – University Of Athens, Department Of Biology, Athens, Greece (2) – B.s.r.c. “alexander Fleming”, Department Of Molecular Oncology, Athens, Greece (3) – Biomedical Research Foundation Of The Academy Of Athens, Department Of Histology, Athens, Greece (4) – Faculty Of Medicine, University Of Athens, Department Of Pathophysiology, Athens, Greece (5) 

100 – Immune dysfunction in Rett syndrome patients revealed by high levels of serum anti-N(Glc) IgM antibody fraction
Anna Maria Papini (1) – Chiara Testa (2) – Anna Aurora Dedonno (1) – Feliciana Real-Fernandez (2) – Silvia Leoncini (3) – Cinzia Signorini (4) – Lucia Ciccoli (4) – Claudio De Felice (5) – Joussef Hayek (6)Paolo Rovero (7)
University Of Florence And University Of Cergy-pontoise, French-italian Interdepartmental Laboratory Of Peptide And Protein Chemistry And Biology. Department Of Chemistry “ugo Schiff”, Sesto Fiorentino, Firenze, Italy (1) – University Of Florence And University Of Cergy-pontoise, French-italian Interdepartmental Laboratory Of Peptide And Protein Chemistry And Biology. Department Of Neurosciences And Pharmaceutical Sciences, Sesto Fiorentino, Firenze, Italy (2) – Azienda Ospedaliera Universitaria Senese And University Of Siena, Child Neuropsychiatry Unit And Department Of Molecular And Developmental Medicine, Siena, Italy (3) – University Of Siena, Department Of Molecular And Developmental Medicine, Siena, Italy (4) – Azienda Ospedaliera Universitaria Senese, Neonatal Intensive Care Unit, Siena, Italy (5) – Azienda Ospedaliera Universitaria Senese, Child Neuropsychiatry Unit, Siena, Italy (6) – University Of Florence, French-italian Interdepartmental Laboratory Of Peptide And Protein Chemistry And Biology. Department Of Neurosciences And Pharmaceutical Sciences, Sesto Fiorentino, Firenze, Italy (7) 

104 – Fumarate improves functional outcome of experimental ischemic stroke
Bettina Hjelm Clausen (1) – Louise Lundberg (1) – Minna Yli-Karjanmaa (1) – Martin Nellie Anne (1) – Martina Svensson (2) – Maria Zeiler Alfsen (1) – Kristina Lyngsø (3) – Antonio Boza-Serrano (2) – Helle Hvilsted Nielsen (4) – Pernille Hansen (5) – Bente Finsen (1) – Thomas Deierborg (2)Zsolt Illes (4) – Kate Lykke Lambertsen (1)
University Of Southern Denmark, Department Of Neurobiology Research, Institute Of Molecular Medicine, Odense C, Denmark (1) – Lund University, Department Of Experimental Medical Sciences, Experimental Neuroinflammation Laboratory,, Lund, Sweden (2) – University Of Southern Denmark, Department Of Cardiovascular And Renal Research, Institute Of Molecular Medicine, Odense C, Denmark (3) – Odense University Hospital, Department Of Neurology, Odense, Denmark (4) – University Of Southern Denmark, Department Of Cardiovascular And Renal Research, Institute Of Molecular Medicine, Odense, Denmark (5) 

125 – Wide-spread inflammation in CLIPPERS syndrome indicated by autopsy and ultrahigh field 7T MRI
Morten Blaabjerg (1) – Klemens Ruprecht (2) – Tim Sinnecker (3) – Daniel Kondziella (4) – Thoralf Niendorf (5) – Bjorg Morell Kerrn-Jespersen (6) – Mette Lindelof (6) – Hans Lassmann (7) – Bjarne Winther Kristensen (8) – Friedemann Paul (2)Zsolt Illes (1)
University Of Southern Denmark, Odense University Hospital Department Of Neurology, Odense, Denmark (1) – Charité – Universitätsmedizin, Clinical And Experimental Multiple Sclerosis Research Center, Berlin, Germany (2) – Charité – Universitätsmedizin, Neurocure Clinical Research Center, Berlin, Germany (3) – Copenhagen University Hospital, Rigshospitalet, Department Of Neurology, Copenhagen, Denmark (4) – Charité – Universitätsmedizin, Experimental And Clinical Research Center, Berlin, Germany (5) – Herlev Hospital, Department Of Neurology, Herlev, Denmark (6) – Medical University Of Vienna, Center For Brain Research, Vienna, Austria (7) – University Of Southern Denmark, Odense University Hospital Department Of Pathology, Odense, Denmark (8) 

105 – Increased concentration of IL-23 and IL-16 in the serum correlate with AQP4-IgG levels in NMO spectrum disorders
Helle Hvilsted Nielsen (1) – Sudhakar Kalluri (2) – Tobias Sejæk (1) – Gro Dale (3) – Thor Petersen (3) – Tunde Csepany (4) – Gabor Lovas (5) – Magdolna Simo (6) – Peter Dioszeghy (7) – Bernhard Hemmer (8) – Zsolt Illes (9)
Odense University Hospital, Department Of Neurology, Odense C, Denmark (1) – Technische Universitet, Department Of Neurology, Klinikum Rechts Der Isar, Munich, Germany (2) – Aarhus University Hospital, Department Of Neurology, Aarhus, Denmark (3) – University Of Debrecen, Department Of Neurology, Debrecen, Hungary (4) – Jahn Ferenc Teaching Hospital, Department Of Neurology, Budapest, Hungary (5) – Semmelweis University, Department Of Neurology, Budapest, Hungary (6) – Josa Andras Teaching Hospital, Department Of Neurology, Nyiregyhaza, Hungary (7) – Technische Universitet, Department Of Neurology, Klinikum Rechts Der Isar/ Munich Cluster For Systems Neurology (synergy), Munich, Germany (8) – Odense University Hospital/university Of Southern Denmark, Department Of Neurology/institute For Clinical Research, Odense C, Denmark (9) 

109 – Restoration of the peripheral immune/inflammatory response correlates with brain injury recovery in a murine model of Alzheimer disease
Giuseppina Cantarella – Giulia Di Benedetto – Renato Bernardini
University Of Catania, Biomedical And Biotechnological Sciences, Catania, Italy

114 – Antibody profiling identifies novel antigenic targets in spinal cord injury patients
Ilse Palmers (1) – Elke Ydens (1) – Eric Put (2) – Bart Depreitere (3) – Helma Bongers-Janssen (4) – Peter Pickkers (5) – Sven Hendrix (6) – Veerle Somers (1)
Hasselt University, Immunology, Diepenbeek, Belgium (1) – Jessa Hospital, Neurosurgery, Hasselt, Belgium (2) – Katholieke Universiteit Leuven And University Hospitals Leuven, Experimental Neurosurgery And Neuroanatomy, Leuven, Belgium (3) – Adelante, Rehabilitation, Hoensbroek, Netherlands (4) – Radboud University, Nijmegen Medical Centre, Intensive Care Medicine, Nijmegen, Netherlands (5) – Hasselt University, Morphology, Diepenbeek, Belgium (6) 

117 – Regulatory Role of Cytosolic Phospholipase A2 Alpha in Induction of CD40 in Microglia
Yafa Fetfet Malada-Edelstein – Nurit Hadad – Rachel Levy
Ben-gurion University Of The Negev And Soroka University Medical Center, Department Of Clinical Biochemistry And Pharmacology, Faculty Of Health Sciences, Immunology And Infectious Diseases Laboratory, Beer-Sheva, Israel

134 – Aberrant activation of classical complement pathway mediates synaptic loss in a mouse model of spinal muscular atrophy
Aleksandra Vukojicic (1) – Nicolas Delestree (1) – Emily V. Fletcher (1) – Sethu Sankaranarayanan (2) – Ted Yednock (2) – Ben A. Barres (3) – George Z. Mentis (1)
Columbia University, Center For Motor Neuron Biology And Disease, Depts. Of Pathology & Cell Biology And Neurology, New York, United States (1) – Annexon Biosciences, 280 Utah Avenue Suite 110, South San Francisco, United States (2) – Stanford University School Of Medicine, Dept. Of Neurobiology, Stanford, United States (3) 

165 – Immune response triggered by aberrant protein oligomers in microglial cells
Benedetta Mannini (1) – Adahir Labrador-Garrido (2) – Giulia Vecchi (1) – Bertrand Fabre (3) – David Pozo (2) – Fabrizio Chiti (4) – Christopher M. Dobson (1) – Michele Vendruscolo (1) – Cintia Roodveldt (2)
University Of Cambridge, Department Of Chemistry, Cambridge, United Kingdom (1) – CABIMER-Andalusian Center for Molecular Biology and Regenerative Medicine, University Of Seville, Seville, Spain (2) – University Of Cambridge, Cambridge Centre For Proteomics, Department Of Biochemistry, Cambridge, United Kingdom (3) – University Of Florence, Department Of Biomedical Experimental And Clinical Sciences, Florence, Italy (4) 

167 – Amyloid beta-reactive T cells as plaque-targeted immune modulators in mouse models of Alzheimer’s disease
Ekaterina Eremenko – Kritika Mittal – Alon Monsonego
The National Institute Of Biotechnology In The Negev; Ben-gurion University Of The Negev, The Shraga Segal Department Of Microbiology, Immunology And Genetics, Faculty Of Health Sciences, Ben-gurion University Of The Negev, Beer-sheva, Israel

200 – The clinical significance of polymorphonuclear leukocytes in the cerebrospinal fluid in patients with aquaporin-4 antibody-positive myelitis
Hiroshi Kuroda (1) – Toshiyuki Takahashi (1) – Douglas Kazutoshi Sato (1) – Yoshiki Takai (1) – Shuhei Nishiyama (1) – Tatsuro Misu (2) – Ichiro Nakashima (1) – Kazuo Fujihara (2) – Masashi Aoki (1)
Tohoku University Graduate School Of Medicine, Department Of Neurology, Sendai, Japan (1) – Tohoku University Graduate School Of Medicine, Department Of Multiple Sclerosis Therapeutics, Sendai, Japan (2) 

203 – Dissecting autoreactive T cell response in CNS autoimmunity
Eric Armentani (1, 5) – Daniela Latorre (1) – Ulf Kallweit (2) – Mauro Manconi (3) – Ramin Khatami (4) – Claudio Bassetti (2) – Antonio Uccelli (5) – Federica Sallusto (1)
Center Of Medical Immunology, Institute For Research In Biomedicine, Universita` Della Svizzera Italiana, Bellinzona, Switzerland (1) – Inselspital, Department Of Neurology, Bern, Switzerland (2) – Neurocenter Of Southern Switzerland, Ente Ospedaliero Cantonale, Lugano, Switzerland (3) – Klinik Barmelweid, Center For Sleep Medicine, Sleep Research And Epileptology, Barmelweid, Switzerland (4) – Department Of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal And Child Health, University Of Genoa, Genoa, Italy (5) 

213 – Study of stroke outcome after experimental cerebral ischemia of the aged
Giorgia Serena Gullotta (1) – Donatella De Feo (1) – Norma Maugeri (2) – Paola Ronchi (3) – Andrea Bergamaschi (4) – Mattia Gallizioli (1) – Giancarlo Comi (1) – Gianvito Martino (1) – Marco Bacigaluppi (1)
San Raffaele Scientific Institute, Università Vita-salute San Raffaele, Division Of Neuroscience- Inspe- Institute Of Experimental Neurology, Neuroimmunology Unit, Milan, Italy (1) – San Raffaele Scientific Institute, Division Of Regenerative Medicine, Stem Cells, And Gene Therapy, Immunohematology And Transfusion Medicine Unit, Milan, Italy (2) – San Raffaele Scientific Institute, Division Of Immunology, Transplantation And Infectious Diseases, Autoimmunity & Vascular Inflammation Unit, Milan, Italy (3) – San Raffaele Scientific Institute, Division Of Neuroscience- Inspe- Institute Of Experimental Neurology, Neuroimmunology Unit, Milan, Italy (4) 

218 – Leukocyte subtype counts in the acute phase of ischemic stroke are predictive of functional outcome and hemorrhagic complications independently of infections
Aurora Semerano (1) – Davide Strambo (2) – Gianvito Martino (1) – Giancarlo Comi (2) – Luisa Roveri (2)Marco Bacigaluppi (1)
San Raffaele Scientific Institute, Department Of Neurology – Institute Of Experimental Neurology, Inspe, Milan, Italy (1) – San Raffaele Scientific Institute, Department Of Neurology, Milan, Italy (2) 

229 – Experimental stroke induces formation of B cell aggregates in the brain and production of CNS-reactive antibodies
Katarzyna Winek (1) – Tian Zhang (1) – Claudia Dames (2) – Ewa Andrzejak (1) – Christian Meisel (2) – Andreas Meisel (1)
Charité – Universitätsmedizin Berlin, Department Of Experimental Neurology, Berlin, Germany (1) – Charité – Universitätsmedizin Berlin, Institute For Medical Immunology, Berlin, Germany (2) 

230 – Circulating myelomonocytic cells do not infiltrate the spinal cord of the mSOD mouse model of ALS
Coral-Ann Lewis (1) – Charles Krieger (2) – Fabio Rossi (1)
Biomedical Research Centre, University Of British Columbia, Vancouver, Canada (1) – Department Of Biomedical Physiology And Kinesiology, Simon Fraser University, Burnaby, Canada (2) 

243 – The double edged sword of immunostimulation after stroke
Claudia Dames (1) – Katarzyna Winek (2) – Andreas Meisel (2) – Christian Meisel (1)
Institute For Medical Immunology, Charité – Universitätsmedizin, Berlin, Germany (1) – Department Of Experimental Neurology, Charité – Universitätsmedizin, Berlin, Germany (2) 

246 – Brain immune surveillance alterations in transgenic models of Alzheimer’s disease-like amyloid pathology
Maria Teresa Ferretti (1) – Claudia Spaeni (1) – Christoph Gericke (1) – Nora Schweizer (2) – Tobias Suter (2) – Luka Kulic (1) – Roger M. Nitsch (1)
Institute For Regenerative Medicine (irem), University Of Zurich, Schlieren, Switzerland (1) – Neurology, Neuroimmunology And Multiple Sclerosis Research, University Hospital Zurich, Zurich, Switzerland (2) 

272 – HIV-1 viral protein R activates NLRP3 inflammasome in microglia: implications for HIV-1 associated neuroinflammation
Manmeet Mamik (1) – William Branton (1) – Brienne Mckenzie (2) – Jesse Chisholm (1) – Christopher Power (1)
University Of Alberta, Department Of Medicine, Edmonton, Canada (1) – University Of Alberta, Department Of Medical Microbiology And Immunology, Edmonton, Canada (2) 

287 – Alcohol, brain neuroimmune/inflammatory signaling, and neurodamage
Michael A. Collins (1) – Nuzhath Tajuddin (1) – Edward J. Neafsey (1) – Hee-Yong Kim (2)
Department of Molecular Pharmacology, Stritch Medical School, Loyola University Chicago, Maywood IL, United States (1) – Laboratory of Molecular Signaling, NIAAA, NIH, Bethesda, MD, USA (2) 

294 – Anti-LAP antibody: a new checkpoint inhibitor for the treatment of glioblastoma
Galina Gabriely – Andre Pires Da Cunha – Brendan Kenyon – Rafael Rezende – Tyler Vandeventer – Murugaiyan Gopal – Howard L. Weiner
Ann Romney Center Of Neurologic Diseases, Brigham And Women’s Hospital, Harvard Medical School, Boston, Ma, United States

310 – Ubiquilin-2 drives NF-κB activity and cytosolic TDP-43 aggregation in neuronal cells
Vincent Picher-Martel (1) – Kallol Dutta (1) – Daniel Phaneuf (1) – Gen Sobue (2) – Jean-pierre Julien (1)
Criusmq, Université Laval, Québec, Canada (1) – Nagoya University Graduate School Of Medicine, Nagoya University, Nagoya, Japan (2) 

325 – The link between pathological changes in astrocytes to the progression of Alzheimer’s disease
Shoshik Amram (1, 2) – Tal Iram (1, 2)Dan Frenkel (1, 2)
Tel Aviv University, Department Of Neurobiology, Faculty Of Life Sciences, Tel Aviv, Israel (1) – Tel Aviv University, Sagol School Of Neuroscience, Tel Aviv, Israel (2) 

339 – Neuroimmune interactions: the VIP-ADNP impact
Illana Gozes
Department Of Human Molecular Genetics And Biochemistry, Sackler Faculty Of Medicine, Adams Super Center for Brain Studies & Sagol School of Neuroscience, Tel Aviv University 69978, Tel Aviv, Israel

345 – Serum IL17 and IL-23 levels have been determined patients who have RR- MS
Nebahat Tasdemir
University Of Dicle Medical Faculty Depart Of Neurology, University Of Dicle Medical Faculty Depart Of Neurology, Diyarbakir, Turkey 

Old and New Paths of Inflammation and Immune Intervention at the Level of the Peripheral Nerves, the NMJ and the Muscles

 3 – Thymus involvement in myasthenia gravis: epidemiological and clinical impacts of different self-tolerance breakdown mechanisms
Arnon Karni – Ali Asmail – Vivian Drory – Hadar Kolb – Anat Kesler
Tel Aviv Medical Center, Sackler’s Medical School, Tel Aviv University, Tel Aviv, Israel

28 – Immunomodulation in Anti-MuSK Myasthenia Gravis
Valeria Serban, MD, Ph.D.
TJU, TJU, Philadelphia, United States

205 – Characterization of the role of miR-150-5p in Myasthenia Gravis
Mélanie Cron (1) – Frédérique Truffault (1) – Ambra Vittoria Gualeni (2) – Annunziata Gloghini (2) – Sonia Berrih-Aknin (1) – Rozen Le Panse (1)
UMRS 974 UPMC – INSERM – Fre 3617 CNRS – Aim, Center of Research in Myology, Paris, France (1) – Department of Pathology and Laboratory Medicine, Istituto Nazionale Dei Tumori, Milano, Italy (2) 

206 – Interleukin-23 level in thymuses of myasthenia gravis patients
Villegas Jose Adolfo – Le Panse Rozen – Berrih-Aknin Sonia – Dragin Nadine
Center of Research in Myology, Sorbonne Universités, UPMC – INSERM Umrs 974, CNRS Fre3617, Institute of Myology, G.h. Pitié-Salpêtrière, Paris, France

211 – AhR may be involved in autoimmune myasthenia gravis
Villegas Jose Adolfo – Khansa Rémi – Le Panse Rozen – Berrih-Aknin Sonia – Dragin Nadine
Center of Research in Myology, Sorbonne Universités, UPMC – INSERM Umrs 974, CNRS Fre3617, Institute of Myology, G.h. Pitié-Salpêtrière, Paris, France

334 – The Role of Slow and Persistent TTX-resistant Sodium Currents in Acute Tumor Necrosis Factor alpha – Mediated Increase in Nociceptors Excitability
Sagi Gudes – Omer Barkai – Yaki Caspi – Ben Katz – Shaya Lev – Alexander M. Binshtok
Institute For Medical Research Israel-canada, The Edmond And Lily Safra Center For Brain Sciences, Department Of Medical Neurobiology, Faculty Of Medicine, The Hebrew University, Jerusalem, Israel

Psychoneuroimmunology: Immunity over Mind and Mind over Immunity

 12 – Mice lacking alpha-beta T cells display a normal cognitive behavior Cláudia Serre-Miranda – Susana Roque – João Pacheco – Joana Palha – Margarida Correia-Neves
Life And Health Sciences Research Institute (icvs), School Of Health Sciences, University Of Minho, Braga, Portugal

39 – Prenatal fluoxetine alters the response to an immune challenge: possible role for glucocorticoid hormones
Ronit Avitsur-Hamiel
School of Behavioral Sciences, The Academic College of Tel Aviv-Yaffo, Tel-Aviv, Israel.

152 – Antidepressant Effects of Acupuncture Via Neuroimmunological Mechanisms
Jun Kawanokuchi (1) – Ken Takagi (1) – Nobuyuki Tanahashi (2) – Kaito Mizuno (1) – Yoshinori Sunami (1) – Akihisa Yamamoto (3) – Atsushi Takeda (3) – Ko Nishimura (1) – Torao Ishida (1)
Institute Of Traditional Chinese Medicine, Suzuka University Of Medical Science, Suzuka, Japan (1) – Clinical Nutrition, Faculty Of Health And Hygiene, Suzuka University Of Medical Science, Suzuka, Japan (2) – Acupuncture And Moxibustion , Faculty Of Health And Hygiene, Suzuka University Of Medical Science, Suzuka, Japan (3) 

174 – Activation of the brain’s reward system attenuates tumor growth in mice Maya Schiller (1) – Tamar Ben-Shaananh (1) – Ben Korin (1) – Hilla Azulay-Debby (1) – Jivan Shakya (1) – Miki Rahat (1) – Fahed Hakim (2) – Asya Rolls (1)
Technion Israel Institute Of Technology, Immunology, Haifa, Israel (1) – Rambam Health Care Campus, Pediatric Pulmonary Unit, Haifa, Israel (2)

175 – A reward for immunity- activation of dopaminergic neurons in the brain’s reward system boost anti-bacterial immunity
Tamar L. Ben-Shaanan (1) – Hilla Azulay-Debby (1) – Tania Dubovik (1) – Elina Starosvetsky (1) – Ben Korin (1) – Maya Schiller (1) – Nathaniel L. Green (1) – Yasmin Admon (1) – Fahed Hakim (2) – Shai S Shen-Orr (1) – Asya Rolls (1)
Technion, Immunology, Haifa, Israel (1) – Rambam Health Care Campus, Pediatric Pulmonary Unit, Haifa, Israel (2) 

195 – Autoantibody profiling of patients with schizophrenia
David Just (1) – Francis Cavallo (1) – Anna Häggmark (1) – Thomas Schulze (2) – Erik Jönsson (3) – Janet Cunningham (4) – Peter Nilsson (1)
Science For Life Laboratory, School Of Biotechnology – Kth, Royal Institute Of Technology, Stockholm, Sweden (1) – Medical Center Of The University Munich, Department Of Psychiatric Phenomics And Genomics, Munich, Germany (2) – Karolinska Institutet, Department Of Clinical Neuroscience, Centre Of Psychiatry Research, Stockholm, Sweden (3) – Uppsala University, Department Of Neuroscience, Psychiatry, Uppsala, Sweden (4) 

271 – A comparison of B cell population in cerebrospinal fluid of healthy controls and patients with schizophrenia
Sehba Husain-Krautter (1) – Anil Malhotra (2) – Thomas Rothstein (3)
Delaware Psychiatric Center (1) – The Zucker Hillside Hospital (2) – Feinstein Institute for Medical Research (3) 

299 – The predictive value of cognitive evaluation in multiple sclerosis
Ron Milo (1) – Jenia Reznuk-Zoref (2) – Omer Hegedish (3) – Semion Kertzman (4)
Barzilai Medical Center, Department Of Neurology, Ashkelon, Israel, and Faculty Of Health Sciences, Ben-Gurion University Of The Negev, Israel (1) – Barzilai Medical Center, Department Of Neurology, Ashkelon, Israel (2) – University Of Haifa, Department Of Psychology, Haifa, Israel (3) – Beer Yaakov Mental Hospital, Sackler School Of Medicine, Tel-Aviv University, Tel-Aviv, Israel (4) 

302 – A follow-up study in Mayor Depressive Disorders: advanced FACS and gene expression analysis
Anna Maria Finardi (1)Sara Di Toro (1) – Cristina Lorenzi (2) – Adele Pirovano (2) – Sara Poletti (2) – Luca Battistini (3) – Giovanna Borsellino (3) – Gualtiero Colombo (4) – Elisa Bono (4) – Francesco Benedetti (2) – Roberto Furlan (1)
San Raffaele, Department Of Clinical Neuroimmunology, Milan, Italy (1) – San Raffaele, Department Of Clinical Neurosciences, Milan, Italy (2) – Santa Lucia Foundation, Neuroimmunology Unit, Roma, Italy (3) – Irccs Monzino, Cardiological Centre, Milano, Italy (4) 

357 – Chronic-stress induces microglial hyper-ramification and up-regulation of cytokines in stress-responsive brain regions
Simone Brioschi – Knut Biber
Uniklinikum Freiburg, University Hospital Psychiatry And Psychotherapy, Freiburg, Germany

379 – The effect of oligodendrogenesis overexpression in the dentate gyrus on hippocampal-related behavior and plasticity
Maayan Krispil (2) – Rachel Anunu (2) – Daniella Kaufer (1) – Gal Richter Levin (2)
Department of Integrative Biology, Helen Wills Neuroscience Institute, University of California, Berkeley, CA, USA (1) – The institute for the study of affective neuroscience , the University of Haifa, Haifa, Israel (2) 

CNS Microglia and Macrophages in Health and Disease. Myeloid Cells in the Brain: Origin, Fate and Effect

9 – Manipulating IFN-I signaling in the brain throughout life reveals a novel homeostatic microglial regulator.
Aleksandra Deczkowska (1) – Orit Matcovitch-Natan (1, 2) – Afroditi Tsitsou-Kampeli (1) – Eyal David (2) – Oded Singer (3) – Lucas K. Smith (4) – Anna Terem (5) – Ami Citri (5) – Saul Villeda (4) – Ido Amit (2) – Michal Schwartz (1)
Department Of Neurobiology, Weizmann Institute Of Science, Rehovot, Israel (1) – Department Of Immunology, Weizmann Institute Of Science, Rehovot, Israel (2) – Faculty Of Biochemistry, Biological Services Unit, Weizmann Institute Of Science, Rehovot, Israel (3) – Department Of Anatomy, University Of California San Francisco, San Francisco, United States (4) – Institute Of Life Sciences, Faculty Of Natural Sciences, The Hebrew University Of Jerusalem, Jerusalem, Israel (5) 

49 – Engulfment of living Th17 cells by microglia within the brain without subsequent cell death
Beatrice Wasser – Dirk Luchtman – Kerstin Robohm – Esther Witsch – Frauke Zipp – Stefan Bittner
Department Of Neurology, University Medical Center Of The Johannes-gutenberg University Mainz, Mainz, Germany

55 – Plasticity of mononuclear phagocytes in an animal model of Multiple Sclerosis
Giuseppe Locatelli (1) – Delphine Theodorou (1) – Athanasios Dagkalis (1) – Marta Jordao (2) – Nora Hagemeyer (2) – Marco Prinz (2) – Thomas Misgeld (3) – Martin Kerschensteiner (1)
Lmu University Munich, Institute For Clinical Neruoimmunology, Munich, Germany (1) – Universitätsklinikum Freiburg, Centrum Für Chronische Immundefizienz (cci), Freiburg, Germany (2) – Technical University Munich, Institute Of Neuronal Cell Biology, Munich, Germany (3) 

63 – Beware the intruder: neutrophil-microglia interactions after stroke in real time
Monika Riek-Burchardt (1) – Sophie Henneberg (2) – Andreas J. Müller (1) – Klaus G. Reymann (3) – Burkhart Schraven (1) – Matthias Gunzer (2) – Jens Neumann (4)
Otto-von-Guericke University, Faculty Of Medicine, Institute Of Molecular And Clinical Immunology, Magdeburg, Germany (1) – University Duisburg-essen, Institute Of Experimental Immunology And Imaging, Essen, Germany (2) – German Centre For Neurodegenerative Diseases (DZNE), Demenz-pathophysiologie, Magdeburg, Germany (3) – Otto-von-Guericke University, Faculty Of Medicine, Department Of Neurology, Magdeburg, Germany (4) 

72 – Functional characterization of microglia: a unique view on primary human microglia in normal appearing multiple sclerosis tissue
Marlijn van der Poel (1) – Suzanne SM Miedema (1) – Mark R Mizee (1) – Jörg Hamann (2) – Inge Huitinga (1)
Netherlands Institute For Neuroscience, Neuroimmunology, Amsterdam, Netherlands (1) – Academical Medical Center, Experimental Immunology, Amsterdam, Netherlands (2) 

106 – Microglia as pH sensors of the brain: sensing tissue acidosis during hypoxia
Louis-Philippe Bernier – Lasse Dissing-Olesen – Jasmin Hefendehl – Jeffrey Ledue – Brian MacVicar
University Of British Columbia, Djavad Mowafaghian Centre For Brain Health, Vancouver, Canada

107 – Role of exosomes in microglia communication and inflammation
Joe C Udeochu – Saul Villeda
University Of California, San Francisco, Anatomy, San Francisco, United States

111 – Deficiency of A20 in microglia leads to spontaneous neuroinflammation
Alma Mohebiany (1) – Bettina Steege (2) – Lisa Hebich (2) – Tana Omokoko (2) – Ari Waisman (1)
Instute For Molecular Medicine, University Medical Center Of The Johannes Gutenberg University Of Mainz, Mainz, Germany (1) – Biontech, Cell & Gene Therapy Gmbh, Mainz, Germany (2) 

115 – Collectin sub-family member 12 expression is increased in active MS lesions and mediates myelin uptake by phagocytes
Jeroen Bogie (1) – Jo Mailleux (1) – Elien Wouters (1) – Winde Jorissen (1) – Jasmine Vanmol (1) – Kristiaan Wouters (2) – Niels Hellings (1) – Jack Van Horssen (3) – Tim Vanmierlo (1) – Jerome Hendriks (1)
Biomedical Research Institute, Hasselt University, Diepenbeek, Belgium (1) – Cardiovascular Research Institute Maastricht (carim),, Maastricht University Medical Centre (mumc), Maastricht, Netherlands (2) – Department Of Molecular Cell Biology And Immunology, Vu University Medical Center, Amsterdam, Netherlands (3) 

120 – Morphological and functional aspects of microglial turnover by circulating monocytes in a mouse model of constitutive microglial ablation Anna Nemirovsky – Strominger Itai – Niva Blum – Omer Berner – Kritika Mittal – Rona Baron – Nitzan Levy – Monsonego Alon
Ben Gurion University Of The Negev, Shraga Segal Department Of Microbiology, Immunology, And Genetics, Beer Sheva, Israel

133 – Neuroprotective role of early activated microglia during preclinical autoimmune optic neuritis
Richard Fairless – Sarah Williams – Ricarda Diem
University Of Heidelberg, Department Of Neurology, Heidelberg, Germany

137 – Immunologic factors that impair remyelination in the aging central nervous system
Khalil S. Rawji – David Tang – Janson Kappen – Michael B. Keough – V. Wee Yong
University Of Calgary, Department Of Clinical Neurosciences And Hotchkiss Brain Institute, Calgary, Canada

143 – MerTK as a Functional Regulator of Anti-inflammatory Myelin Phagocytosis by Human Myeloid Cells
Luke Healy (1) – Gabrielle Perron (1) – So-Yoon Won (1) – Craig Moore (2) – Amit Bar-Or (1) – Jack Antel (1)
Montreal Neurological Institute, Mcgill University, Montreal, Canada (1) – Division Of Biomedical Sciences, Memorial University, St. Johns, Canada (2) 

150 – Erythropoietin dampens injury-induced microglial activity
Hana Janova (1) – Miso Mitkovski (2) – Liane Dahm (1) – Hong Pan (1) – Vivien Charlott Schwingel (1) – Klaus-Armin Nave (3) – Hannelore Ehrenreich (1)
Max Planck Institute Of Experimental Medicine, Clinical Neuroscience, Goettingen, Germany (1) – Max Planck Institute Of Experimental Medicine, Light Microscopy Facility, Goettingen, Germany (2) – Max Planck Institute Of Experimental Medicine, Department Of Neurogenetics, Goettingen, Germany (3) 

156 – Multi-dimensional characterization of the brain’s immune populations and their modification under peripheral infection
Ben Korin – Nathaniel Green – Tamar Ben Shaanan – Tania Dubovik – Asya Rolls
Technion, Israel Institute Of Technology, Department Of Immunology, Rappaport Medical School, Haifa, Israel

173 – Neuroprotective role of microglia in postnatal brain
Yuki Fujita – Toshihide Yamashita
Graduate School Of Medicine, Osaka University, Department Of Molecular Neuroscience, Osaka, Japan

176 – Microglia development follows a stepwise program to regulate brain homeostasis
Orit Matcovitch-Natan (1) – Deborah Winter (2) – Shalev Itzkovitz (3) – Eran Elinav (2) – Michael H. Sieweke (4) – Michal Schwartz (5) – Ido Amit (2)
Weizmann Institute, Department Of Neurobiology And Department Of Immunology, Rehovot, Israel (1) – Weizmann Institute, Department Of Immunolgy, Rehovot, Israel (2) – Weizmann Institute, Department Of Cell Biology, Rehovot, Israel (3) – Université Aix-marseille, Um2, Campus De Luminy, Centre D’immunologie De Marseille-luminy, Marseille, France (4) – Weizmann Institute, Department Of Neurobiology, Rehovot, Israel (5) 

184 – TREM2-APOE signaling induces dysfunctional microglia in neurodegeneration
Charlotte Madore
Harvard Medical School, Brigham And Women’s Hospital, Boston, United States

199 – ATP-induced IL-1beta secretion is selectively impaired in microglia as compared to hematopoietic macrophages
Saskia Burm – Ella Zuiderwijk-Sick – Paola Weert – Jeffrey Bajramovic
Biomedical Primate Research Centre, Alternatives, Rijswijk, Netherlands

212 – Macrophage Involvement in IL-9 Mediated Neuroprotection in Multiple Sclerosis
Inbar Saraf-Sinik (1) – Stefania Rossi (2) – Roberta Magliozzi (2) – Luca Battistini (1) – Elisabetta Volpe (1)
Santa Lucia Foundation, Neuroimmunology, Rome, Italy (1) – University Of Verona, Neurological And Movement Sciences, Verona, Italy (2) 

217 – Teriflunomide Impacts Primary Microglia and Astrocyte Functions In Vitro
Andrea Edling – Lisa Woodworth – Rajiv Agrawal – Amy Mahan – Tracy Garron – Nellwyn Hagan – Bill Siders
Sanofi Genzyme, Neuroimmunology Research, Framingham, United States

222 – IL-34 deficiency does not influence acute ischemic stroke outcome Hélène Descamps * (1) – Marco Bacigaluppi * (1) – Donatella De Feo (1) – Iva Lelios (2) – Elena Brambilla (1) – Burkhard Becher (2) – Melanie Greter (2) – Gianvito Martino (1)
San Raffaele Scientific Institute, University Vita-salute San Raffaele, Milan, Italy (1) – Institute Of Experimental Immunology, University Of Zurich, Zurich, Switzerland (2) 

231 – Deficient antigen presentation by arginase-expressing dendritic cells in autoimmune demyelinating disease
David Giles – Benjamin Segal
University Of Michigan, Neurology, Ann Arbor, United States

250 – High-resolution characterization of microglia differentiation in the developing zebrafish
Niva Russek- Blum (1) – Moriya Avneri (1, 2) – Alon Monsonego (2)
The Dead Sea And Arava Science Center, Central Arava Branch, Hazeva, Israel (1) – Ben-gurion University, The Shraga Segal Dept. Of Microbiology, Immunology And Genetics. The Faculty Of Health Sciences, And The National Institute Of Biotechnology, Beer-sheva, Israel (2) 

258 – Characterization of the pathogenic role of microglia in a mouse model of retinitis pigmentosa
Panayota Kolypetri (1) – Gennadi Landa (1) – Charlotte Madore (1) – Bruce Ksander (2) – Hans Lassmann (3) – Oleg Butovsky (1) – Howard Weiner (1)
Ann Romney Center For Neurologic Diseases, Brigham And Women’s Hospital, Harvard Medical School, Boston, United States (1) – Schepens Eye Research Institute, Massachusetts Eye And Ear Infirmary, Harvard Medical School, Boston, United States (2) – Center For Brain Research, Department Of Neuroimmunology, Medical University Vienna, Vienna, Austria (3) 

269 – Acute purification of human adult microglia from the post-mortem brain. A systematic validation study
Mark Mizee (1) – Suzanne Miedema (2) – Adelia Adelia (1) – Karianne Schuurman (1) – Jorg Hamann (3) – Inge Huitinga (4)
Netherlands Brain Bank For Psychiatry, Netherlands Institute For Neuroscience, Amsterdam, Netherlands (1) – Immunology Research Group, Netherlands Institute For Neuroscience, Amsterdam, Netherlands (2) – Academic Medical Center Amsterdam, Academic Medical Center Amsterdam, Amsterdam, Netherlands (3) – Netherlands Brain Bank, Netherlands Institute For Neuroscience, Amsterdam, Netherlands (4) 

293 – Exposure to 3-nitropropionic acid mitochondrial toxin induces tau pathology in tangle-mouse model and in wild type-mice mediated by a microglial response
Inbal Lahiani-Cohen (1) – Nikolaos Grigoriadis (2) – Lea Rozenstein-Tsalkovich (1) – Athanasios Lourbopoulos (2) – Olga Touloumi (2) – Oded Abramsky (1) – Hanna Rosenmann (1)
Hadassah Hebrew University Medical Center, The Department Of Neurology, The Agnes Ginges Center For Human Neurogenetics, Jerusalem, Israel (1) – Ahepa University Hospital, The B’ Department Of Neurology, Thessaloniki, Macedonia, Greece (2) 

309 – Dual role of microglia in mediating the central response to peripheral inflammation
Karin Riester – Bianca Brawek – Daria Savitska – Elizabeta Zirdum – Olga Garaschuk
Institute Of Physiology II, Eberhard Karls University, Tuebingen, Germany 

311 – Ly6CHigh inflammatory monocytes mediate microglial dysfunction via Apoe and Galectin-3 signaling in experimental autoimmune encephalitis (EAE)
Elaine O’Loughlin (1) – Pilar Lopez-Cotarelo (2) – Charlotte Madore (1) – Scott Smith (1) – George Tweet (1) – Oleg Butovsky (1)
Brigham And Women’s Hospital, Harvard Medical School, Department Of Neurology, Boston, United States (1) – Consejo Superior De Investigaciones Científicas, Centro De Investigaciones Biológicas, Madrid, Spain (2) 

312 – Microglia transiently clear prions from the brain after retroviral infection but do not change incubation time
Susanne Krasemann (1, 2) – Katharina Schroeck (1) – Charlotte Madore (2) – Christiane Muth (1) – Kristin Hartmann (1) – Zain Fanek (2) – Markus Glatzel (1) – Oleg Butovsky (2)
Institute Of Neuropathology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany (1) – Brigham And Women’s Hospital, Harvard Medical School, Department Of Neurology, Boston, United States (2) 

314 – M2 microglia polarization: implications in neurodegenerative diseases Giovanna Pepe – Alessandro Villa – Adriana Maggi – Elisabetta Vegeto
University Of Milan, Department Of Pharmacological And Biomolecular Sciences, Milan, Italy

317 – An ATP-independent release of shedding vesicles from myeloid cells Federico Colombo (1) – Annamaria Nigro (2) – Giacomo Casella (3) – Roberto Furlan (2)
Università Vita Salute San Raffaele, Institute Of Experimental Neurology, Milano, Italy (1) – Ospedale San Raffaele, Institute Of Experimental Neurology, Milan, Italy (2) – Università Vita Salute San Raffaele, Institute Of Experimental Neurology, Milan, Italy (3) 

321 – The form-function connection of M1/M2 microglia revisited
Beatrice Wasser – Dirk Luchtman – Kerstin Robohm – Frauke Zipp – Stefan Bittner University Of Mainz, Neurology, Mainz, Germany

323 – The role of DJ-1 in mediating microglia activity toward alpha synuclein Yuval Nash (1) – Eran Schmukler (2) – Dorit Trudler (1) – Ronit Pinkas-Kramarski (2) – Dan Frenkel (2)
Tel Aviv University, Sagol School Of Neuroscience, Tel Aviv, Israel (1) – Tel Aviv University, Department Of Neurobiology, George S. Wise Faculty Of Life Sciences, Tel Aviv, Israel (2) 

358 – Microglia mediate the anti-depressive effects of electroconvulsive shock therapy in mice exposed to chronic unpredictable stress
Neta Rimmerman – Ronen Reshef – Maayan Abargil – Laura Cohen – Raz Yirmiya Department Of Psychology, The Hebrew University, Jerusalem, Israel. 

361 – The farnesoid-X-receptor in myeloid cells controls central nervous system autoimmunity in an IL-10-dependent fashion
Martin Herold (1) – Stephanie Hucke (1) – Marie Liebmann (1) – Nicole Freise (2) – Maren Lindner (1) – Ann-Katrin Fleck (1) – Stefanie Zenker (2) – Stephanie Thiebes (3) – Juncal Fernandez-Orth (1) – Dorothea Bock (4) – Felix Luessi (5) – Sven G. Meuth (1) – Frauke Zipp (5) – Bernhard Hemmer (4) – Daniel Robert Engel (3) – Johannes Roth (2) – Tanja Kuhlmann (6) – Heinz Wiendl (1) – Luisa Klotz (1)
University Of Muenster, Neurology, Muenster, Germany (1) – University Of Muenster, Immunology, Muenster, Germany (2) – University Duisburg-essen, Institute Of Experimental Immunology And Imaging, Essen, Germany (3) – Technical University Of Munich, Neurology, Munich, Germany (4) – University Of Mainz, Neurology, Mainz, Germany (5) – University Of Muenster, Institute Of Neuropathology, Muenster, Germany (6) 

381 – The role of microglia in adult neurogenesis
Ronen Reshef (1) – Elena Kudryavitskay (2) – Haran Shani (2) – Neta Rimmerman (1) – Adi Mizrahi (2) – Raz Yirmiya (1)
Dept. of Psychology, The Hebrew University of Jerusalem, Jerusalem, Israel (1) – Dept of Neurobiology , The Hebrew University of Jerusalem (2) 

The Double Edged Sword of Immunity in Neurodegeneration 

22 – Relationship between microvesicles and free radicals in multiple sclerosis patients
Maira Gironi – Gloria Dalla Costa – Annamaria Finardi – Vittorio Martinelli – Giancarlo Comi – Roberto Furlan
Fondazione Ospedale San Raffaele,milano, Ospedale San Raffaele,milano, Milano

44 – T cells secretion of neurogenic factors is biased toward pro-astrogenesis on the expense of neuronal and oligodendroglial genesis in relapsing remitting multiple sclerosis
Karin Mausner-Fainberg (1)Arnon Karni (2)
Neuroimmunology Laboratory, Department Of Neurology, Tel Aviv Medical Center, Mevaseret Zio, – (1) – Neuroimmunology Laboratory, Department Of Neurology, Tel Aviv Medical Center, Mevaseret Zio, Israel (2) 

51 – Cellular investigations with human antibodies associated with the IgLON5 syndrome
Lidia Sabater (1) – Jesús Planagumà (2) – Josep Dalmau (3) – Francesc Graus (4)
Institut D’investigacions Biomediques August Pi I Sunyer (IDIBAPS). Fundació Clinic., Hospital Clinic De Barcelona/Neuroimmunology Group, Barcelona, Spain (1) – Institut D’investigacions Biomediques August Pi I Sunyer (IDIBAPS)., Hospital Clinic De Barcelona/Neuroimmunology Group, Barcelona, Spain (2) – Institut D’investigacions Biomediques August Pi I Sunyer (IDIBAPS). Institució Catalana De Recerca (ICREA). University Of Pennsylvania, Usa, Hospital Clinic De Barcelona/neuroimmunology Group, Barcelona, Spain (3) – Institut D’investigacions Biomediques August Pi I Sunyer (IDIBAPS). Service Of Neurology, Hospital Clinic De Barcelona, University Of Barcelona, Hospital Clinic De Barcelona/Neuroimmunology Group, Barcelona, Spain (4) 

57 – Reactivity profile of plasma naturally occurring anti-tau antibodies evaluated using post-translationally modified tau forms
Lenka Hromadkova (1, 2, 3) – Michala Kolarova (1, 4) – Ales Bartos (1, 4) – Jan Ricny (1) – Zuzana Bilkova (3)
Department of Experimental Neurobiology and AD Center, National Institute of Mental Health, Klecany, Czech Republic (1) – Faculty of Science, Charles University in Prague, Prague, Czech Republic (2) – Department of Biological and Biochemical Sciences, University of Pardubice, Pardubice, Czech Republic (3) – Third Faculty of Medicine, Charles University in Prague, Prague, Czech Republic (4) 

154 – TGF-β induces differential signaling in astrocytes and microglia Ekaterina Vinogradov – Nitzan Levy – Alon Monsonego
Ben Gurion University Of The Negev, Shraga Segal Department Of Microbiology, Immunology, And Genetics, Beer Sheva, Israel

240 – Understanding Remyelination Failure: GM-CSF Blocks Oligodendrocyte Progenitor Cell Differentiation
Andrew Robinson – Kyle Lyman – Haley Titus – William Lindstrom – Igal Ifergan – Joseph Podojil – Stephen Miller
Northwestern University, Microbiology-immunology Department, Chicago, United States

305 – A new rodent model of progressive demyelination and neurodegeneration mimicking progressive MS
Erika Avendaño-Guzmán (1) – Benoit Barrette (2) – Ramona Theiss (1) – Nielsen Lagumersindez-Denis (1) – Liat Hayardeny (3) – Christine Stadelmann-Nessler (1) – Klaus-Armin Nave (2) – Wolfgang Brück (1) – Stefan Nessler (1)
University Medical Center, Neuropathology, Göttingen, Germany (1) – Max-Planck-Institute of Experimental Medicine, Neurogenetics, Göttingen, Germany (2) – Teva Pharmaceutical Industries, Research And Development, Netanya, Israel (3) 

353 – Innate Immune response in traumatic Spinal Cord Injury (SCI), killing or healing?
Masoud Hassanpour Golakani (1) – Mohammad Ghaleb Mohammad (2) – Hui Li (1) – Manvendra Saxena (1) – Samuel Breit (1) – Marc Ruitenberg (3) – Gill Webster (4) – David Brown (1)
St Vincent’s Centre For Applied Medical Research (amr) / The University Of New South Wales (unsw), Laboratory Of Neuroinflammation, Sydney, Australia (1) – University Of Sharjah, Department Of Medical Laboratory Sciences, Faculty Of Health Sciences, Sharjah, United Arab Emirates (2) – The University Of Queensland (uq), Queensland Brain Institute, Brisbane, Australia (3) – Innate Immunotherapeutics, Innate Immunotherapeutics, Auckland, New Zealand (4) 

371 – Microglia-astrocytic response to experimentally induced neurofibrillary degeneration in animal model of tauopathy
Peter Filipcik (1,2) – Martin Cente (1,2) – Norbert Zilka (1,2) – Branislav Kovacech (1,2) – Michal Novak (1,2)
Institute of Neuroimmunology, Slovak Academy of Sciences, Dubravska cesta 9, 84510 Bratislava, Slovakia (1) – Axon Neuroscience R&D Services, Dvorakovo nabrezie 10, 811 02 Bratislava, Slovakia (2) 

"

Thursday September 29, 2016

Pathogenetic Immune Mechanisms in Neuroinflammation and Demyelination in EAE and Multiple Sclerosis

19 – NIK promotes the generation of functional encephalitogenic effector T-cells
Sonja M. Lacher (1) – Stefan Tenzer (2) – Khalad Karram (1) – Beate Lorenz (3) – Matthias Klein (2) – Tobias Bopp (2) – Esther von Stebut (3) – Florian C. Kurschus (1) – Ari Waisman (1)
Institute For Molecular Medicine, University Medical Center Of The Johannes-Gutenberg University Mainz, Mainz, Germany (1) – Institute For Immunology, University Medical Center Of The Johannes-Gutenberg University Mainz, Mainz, Germany (2) – Department Of Dermatology, University Medical Center Of The Johannes-Gutenberg University Mainz, Mainz, Germany (3) 

23 – The G-protein-coupled receptor EBI2 is highly expressed in MS lesions and promotes early CNS migration of encephalitogenic Th17 cells in EAE Florian Wanke (1) – Andrew L. Croxford (2) – Sonja Moos (1) – André P. Heinen (1) – Stephanie Firmenich (1) – Denise Tischner (3) – Yilang Tang (1) – Morad Zayoud (1) – Nicole Israel (1) – Khalad Karram (1) – Julia Bruttger (1) – Sonja Reißig (1) – Sonja Lacher (1) – Christian Reichhold (1) – Ilgiz A. Mufazalov (1) – Tanja Kuhlmann (4) – Nina Wettschureck (3) – Andreas W. Sailer (5) – Klaus Rajewsky (6) – Stefano Casola (7) – Ari Waisman (1)Florian C. Kurschus (1)
Institute For Molecular Medicine, University Medical Center Of The Johannes Gutenberg-university Mainz, Mainz, Germany (1) – Institute Of Experimental Immunology, University Of Zurich, Zurich, Switzerland (2) – Max Planck Institute For Heart And Lung Research, Max Planck Institute For Heart And Lung Research, Bad Nauheim, Germany (3) – Institute Of Neuropathology, University Hospital Münster, Münster, Germany (4) – Developmental And Molecular Pathways, Novartis Institutes For Biomedical Research, Basel, Switzerland, Basel, Switzerland (5) – Max-delbrueck-center For Molecular Medicine, Max-delbrueck-center For Molecular Medicine, Berlin-buch, Germany (6) – Ifom, The Firc Institute Of Molecular Oncology, Milan, Italy (7) 

34 – DNA methylation changes in brains from Multiple Sclerosis patients
Lara Kular (1) – Maria Needhamsen (1) – Tatiana Kramarova (1) – David Gomez-Cabrero (2) – Ewoud Ewing (1) – Milena Z Adzemovic (1) – Jesper Tegnér (2) – Lou Brundin (1) – Maja Jagodic (1)
Karolinska Institute, Dept Of Clinical Neuroscience, Karolinska University/hospital, Stockholm, Sweden (1) – Karolinska Institute, Dept Of Medicine, Karolinska University/hospital, Stockholm, Sweden (2) 

35 – C-type lectin receptors modulate experimental autoimmune encephalomyelitis
Marie N’diaye (1) – Sevasti Flytzani (1) – Susanna Brauner (1) – Andreas Warnecke (1) – Lara Kular (1) – Eliane Piket (1) – Milena Z Adzemovic (1) – Michael R Daws (2) – Tomas Olsson (1) – Andre Ortlieb Guerreiro-Cacais (1) – Maja Jagodic (1)
Karolinska Institutet – Department Of Clinical Neuroscience, Center for Molecular Medicine, Stockholm, Sweden (1) – University Of Oslo – Department Of Anatomy, University Of Oslo, Oslo, Norway (2) 

37 – DNA methylation profiles in four immune cell types from Multiple Sclerosis patients: shared and cell type-specific methylation changes
Ewoud Ewing (1) – Sabrina Ruhrmann (1) – Lara Kular (1) – Yun Liu (2) – Jesper Tegner (1) – Nestoras Karanthanasis (3) – Vincenzo Lagini (4) – Ioannis Tsamaridinos (4) – Andrew P. Feinberg (2) – Frederik Piehl (1) – David Gomez-Cabrero (1) – Maja Jagodic (1)
Karolinska Institutet, Karolinska Sjukhuset, Stockholm, Sweden (1) – Center For Epigenetics, Johns Hopkins University School Of Medicine, Baltimore, United States (2) – Institute Of Computer Science Forth, University Of Crete, Heraklion, Greece (3) – Computer Science Department, University Of Crete, Heraklion, Greece (4) 

42 – Autophagy-mediated antigen presentation in CNS autoimmunity
Christian W. Keller – Christina Sina – Giulia Ramelli – Isaak Quast – Christian Münz – Jan D. Lünemann
Institute Of Experimental Immunology, University Of Zurich, Zurich, Switzerland

47 – Dysregulation of Repressor Element 1-Silencing Transcription factor in a mouse model of multiple sclerosis
Valentina Petrosino (1) – Stefania Criscuolo (2) – Federica Buffolo (2) – Fabrizia Cesca (2) – Nicole Kerlero De Rosbo (2) – Fabio Benfenati (2) – Antonio Uccelli (1)
Department Of Neurosciences, Rehabilitation, Ophthalmology, Genetics, Maternal And Child Health (dinogmi), University Of Genoa, Genoa, Italy (1) – Center For Synaptic Neuroscience, Istituto Italiano Di Tecnologia (iit), Genoa, Italy (2) 

48 – RNA-binding protein HuR regulates CCR6 expression on Th17 cells
Jing Chen (1) – Jennifer Martindale (2) – Carole Cramer (3) – Myriam Gorospe (2) – Ulus Atasoy (4) – Paul Drew (5) – Shiguang Yu (1)
Department Of Neurology, Thomas Jefferson University, Philadelphia, United States (1) – Laboratory Of Genetics, National Institute On Aging-intramural Research Program, Nih, Baltimore, United States (2) – Department Of Biological Sciences And Abi, Arkansas State University, Jonesboro, United States (3) – Department Of Mmi, University Of Missouri, Columbia, United States (4) – Department Of Neurobiologiy And Developmental Sciences, University Of Arkansas For Medical Sciences, Little Rock, United States (5) 

58 – T cell-mediated CNS autoimmunity can be initiated by myelin-reactive antibodies opsonizing CNS antigen
Silke Kinzel (1) – Sebastian Torke (1) – Claude C. Bernard (2) – Patrice H. Lalive (3) – Markus Reindl (4) – Albert Saiz (5) – Wolfgang Brück (1)Martin Weber (1)
University Medical Center Göttingen, Institute Of Neuropathology, Göttingen, Germany (1) – Monash University, Monash Immunology And Stem Cell Laboratories, Melbourne, Australia (2) – University Hospital Of Geneva, Department Of Pathology And Immunology , Faculty Of Medicine, Geneva, Switzerland (3) – Medical University Of Innsbruck, Clinical Department Of Neurology, Innsbruck, Austria (4) – University Of Barcelona, Hospital Clinic, Service Of Neurology, Barcelona, Spain (5)

59 – Metabolism and autoimmunity: how protein catabolism modulates autoimmune inflammation
Andre Ortlieb Guerreiro-Cacais – Rasmus Berglund – Maja Jagodic – Tomas Olsson Karolinska Institutet, Department Of Clinical Neuroscience, Stockholm, Sweden

66 – Neutrophil perversion in demyelinating autoimmune diseases: mechanisms to medicine
Vallieres Luc – Ryder Whittaker Hawkins – Alexandre Patenaude – Aline Dumas
Laval University, Molecular Medicine, Quebec, Canada

69 – Inflammation drives mitochondrial dysfunction and associated neurodegeneration in multiple sclerosis
Philip Nijland (1) – Maarten Witte (2) – Richard Reynolds (3) – Jack Van Horssen (1) 
Vu University Medical Center, Molecular Cell Biology And Immunology, Amsterdam, Netherlands (1) – Institute Of Clinical Neuroimmunology, Ludwig-maximilians University, Munich, Germany (2) – Division Of Brain Sciences, Faculty Of Medicine, Imperial College London, London, United Kingdom (3) 

70 – Identification of vitamin D responsive multiple sclerosis susceptibility genes in CD4+ T cells
Tone Berge (1) – Ina Brorson (1, 2) – Ingvild Leikfoss (1, 2) – Steffan Bos (1, 2) – Christian Page (1, 2) – Marte Gustavsen (2) – Anja Bjølgerud (1, 2) – Trygve Holmøy (3) – Elisabeth Celius (1) – Jan Damoiseaux (4) – Joost Smolders (5) – Hanne Harbo (1, 2) – Anne Spurkland (6) 
Oslo University Hospital, Neuroscience Research Unit, Department Of Neurology, Oslo, Norway (1) – University Of Oslo, Institute Of Clinical Medicine, Oslo, Norway (2) – Akershus University Hospital, Department Of Neurology, Lørenskog, Norway (3) – Maastricht University Medical Center, Central Diagnostic Laboratory, Maastricht, Netherlands (4) – Wilhelmina Hospital, Department Of Neurology, Nijmegen, Netherlands (5) – University Of Oslo, Institute Of Basic Medical Sciences, Oslo, Norway (6) 

73 – In search of a model for studying alternate autoimmunity post anti- CD52 treatment
Yohannes Haile – Colin C. Anderson
University Of Alberta, Alberta Diabetes Institute, Department Of Surgery, Edmonton, Canada

79 – Allelic imbalance of multiple sclerosis susceptibility genes IKZF3 and IQGAP1 in human peripheral blood
Pankaj Kumar Keshari (1) – Hanne F. Harbo (1) – Kjell M Myhr (2) – Jan H Aarseth (2) – Steffan D Bos (1) – Tone Berge (1) 
Department Of Neurology, Oslo University Hospital, Institute Of Clinical Medicine, University Of Oslo, Oslo, Norway (1) – Norwegian Multiple Sclerosis Registry And Biobank, Department Of Neurology, Haukeland University Hospital, Kg Jebsen Centre For Ms-research, Department Of Clinical Medicine, University Of Bergen, Bergen, Norway (2) 

87 – Pathological heterogeneity in the multiple sclerosis post mortem cohort of the Netherlands Brain Bank relates to clinical course and gender 
Inge Huitinga (1) – Matthew Mason (2) – Nina Fransen (3) – Corbert Van Eden (1) – Sabina Luchetti (3) 
Netherlands Institute For Neuroscience, Dept. Of Neuroimmunology And The Netherlands Brain Bank, Amsterdam, Netherlands (1) – Netherlands Institute For Neuroscience, Dept. Of Neurodegeneration, Amsterdam, Netherlands (2) – Netherlands Institute For Neuroscience, Dept. Of Neuroimmunology, Amsterdam, Netherlands (3) 

89 – Inflammasome activation and modulation in the central nervous system during multiple sclerosis and experimental autoimmune encephalomyelitis Brienne Mckenzie (1) – Manmeet Mamik (2) – Roobina Boghozian (2) – William Branton (2) – Jian-qiang Lu (3) – Christopher Power (2) 
University Of Alberta, Department Of Medical Microbiology And Immunology, Alberta, Canada (1) – University Of Alberta, Department Of Medicine, Edmonton, Canada (2) – University Of Alberta, Department Of Laboratory Medicine And Pathology, Edmonton, Canada (3) 

90 – Mechanisms of demyelination induced by lysolecithin 
Jason Plemel (1) – Nathan Michaels (1) – Michael B. Keough (1) – Jim Rogers (1) – Aran Yukseloglu (1) – Jaehyun Lim (1) – Wulin Teo (1) – Belinda Heyne (2) – Peter Stys (1) – V. Wee Yong (1) 
University Of Calgary, Department Of Clinical Neurosciences, Hotchkiss Brain Institute, Calgary, Canada (1) – University Of Calgary, Department Of Chemistry, Calgary, Canada (2) 

91 – Investigating the role of EMMPRIN and its regulation of monocarboxylate transporters in a model of multiple sclerosis
Deepak K Kaushik – Jennifer N Hahn – V Wee Yong
Hotchkiss Brain Institute, University Of Calgary, Calgary, Canada

97 – High Dimensional Analysis of the Myeloid Landscape in Multiple Sclerosis
Brian Leung (1) – Raul Catena (2) – Alonso Barrantes (3) – Bettina Schreiner (1) – Terrence Town (4) – Christine Stadelmann-Nessler (3) – Bernd Bodenmiller (2) – Burkhard Becher (1) 
Universität Zürich, Experimental Immunology, Zürich, Switzerland (1) – Universität Zürich, Institute For Molecular Life Sciences, Zürich, Switzerland (2) – Universitätsmedizin Göttingen, Institut Für Neuropathologie, Göttingen, Germany (3) – University Of Southern California, Biophysics And Physiology, Los Angeles, United States (4) 

98 – Antibodies from multiple sclerosis patients preferentially recognize hyperglucosylated adhesin of nontypeable Haemophilus influenzae 
Chiara Testa (1) – Marthe T C Walvoort (2) – Raya Eilam (3) – Rina Ahroni (4) – Ruth Arnon (4) – Francesca Nuti (5) – Feliciana Real-Fernandez (1) – Roberta Lanzillo (6) – Vincenzo Brescia Morra (6) – Francesco Lolli (7) – Paolo Rovero (1) – Barbara Imperiali (2)Anna Maria Papini (5) 
University of Florence and University of Cergy-Pontoise, French-Italian Interdepartmental Laboratory of Peptide and Protein Chemistry and Biology. Department of Neurosciences and Pharmaceutical Sciences, Sesto Fiorentino, Firenze, Italy (1) – Massachusetts Institute of Technology, Departments of Biology and Chemistry, Cambridge, MA, United States (2) – The Weizmann Institute of Science, Department of Veterinary Resources, Rehovot, Israel (3) – The Weizmann Institute of Science, Department of Immunology, Rehovot, Israel (4) – University of Florence and University of Cergy-Pontoise, French-Italian Interdepartmental Laboratory of Peptide and Protein Chemistry and Biology. Department of Chemistry “Ugo Schiff”, Sesto Fiorentino, Firenze, Italy (5) – Federico II University, Multiple Sclerosis Clinical Care and Research Centre, Department of Neurosciences, Reproductive Sciences and Odontostomatology, Napoli, Italy (6) – University of Florence, French-Italian Interdepartmental Laboratory of Peptide and Protein Chemistry and Biology, Department of Biomedical, Experimental and Clinical Sciences, Firenze, Italy (7) 

103 – Functional effects of antibodies specific for myelin proteolipid protein in multiple sclerosis
Judith Greer (1) – Elisabeth Trifilieff (2) – Shannon Beasley (1) – Michael Pender (3) 
The University Of Queensland, Uq Centre For Clinical Research, Brisbane, Australia (1) – Université De Strasbourg, Institut De Physique Biologique, Strasbourg, France (2) – The University Of Queensland, Medicine, Brisbane, Australia (3) 

108 – Anti-SPAG16 antibodies are associated with an elevated progression index in progressive multiple sclerosis 
Laura de Bock (1) – Judith Fraussen (1) – Luisa M Villar (2) – José C. Álvarez-Cermeño (2) – Bart Van Wijmeersch (1) – Vincent van Pesch (3) – Piet Stinissen (1)Veerle Somers (1) 
Hasselt University, Biomedical Research Institute and Transnationale Universiteit Limburg, Diepenbeek, Belgium (1) – Ramón Y Cajal Hospital, Departments Of Neurology And Immunology, Madrid, Spain (2) – Université Catholique De Louvain, Institute Of Neurosciences, Neurochemistry Unit, Brussels, Belgium (3) 

110 – Potential regulation of multiple sclerosis by gut homing CCR9+ TH cells Atsushi Kadowaki – Ryoko Saga – Youwei Lin – Wakiro Sato – Takashi Yamamura
National Institute Of Neuroscience, National Center Of Neurology And Psychiatry, Department Of Immunology, Tokyo, Japan

112 – Neuronal response to Multiple Sclerosis
Sabina Berl (1) – Federico Marini (2) – Harald Binder (2) – Ari Waisman (1) 
Molecular Medicine, University Medical Center, Mainz, Germany (1) – Institute Of Medical Biostatistics, Epidemiology And Informatics, University Medical Center, Mainz, Germany (2) 

116 – LINGO-1, p75, TROY (NgR complex) spatiotemporal expression pattern in the spinal cord of EAE mice
Paschalis Theotokis (1) – Olga Touloumi (1) – Roza Lagoudaki (1) – Evangelia Nousiopoulou (1) – Evangelia Kesidou (1) – Athanasios Lourbopoulos (2) – Dimitrios Karacostas (1)Nikolaos Grigoriadis (1) 
Aristotle University Of Thessaloniki, Ahepa University Hospital, Thessaloniki, Greece (1) – Center For Stroke And Dementia Research (csd), Biomedical Research Campus Lmu, Munich, Germany (2) 

119 – The equilibrium of M1/M2 macrophages is altered in multiple sclerosis and its experimental animal model 
Valerio Chiurchiù (1) – Alessandro Leuti (1) – Antonietta Gentile (1) – Maria Albanese (2) – Diego Fresegna (1) – Silvia Bullitta (1) – Diego Centonze (3) – Mauro Maccarrone (4) – Luca Battistini (1) 
Irccs Santa Lucia Foundation, European Center For Brain Research (cerc), Rome, Italy (1) – Multiple Sclerosis Clinical And Research Center, Tor Vergata University And Hospital, Rome, Italy (2) – Irccs Istituto Neurologico Mediterraneo, Neuromed Pozzilli, Rome, Italy (3) – School Of Medicine And Center Of Integrated Research, Campus Bio-medico University Of Rome, Rome, Italy (4) 

124 – Post-translational modifications of MBP in the spinal cord in a mouse EAE model of MS
Ting Zhou (1) – Tina Khorshid Ahmad (2) – Kiana Gozda (2) – Jessica Truong (2) – Ryan Lillico (2) – Nicholas Stesco (2) – Ted Lakowski (2) – Jiming Kong (3) – Mike Namaka (1)
Faculty Of Health Sciences, College Of Pharmacy & Department Of Human Anatomy And Cell Science, College Of Medicine, University Of Manitoba, Winnipeg, Canada (1)(2) – Department Of Human Anatomy And Cell Science, College Of Medicine, University Of Manitoba.ca, Winnipeg, Canada (3) 

126 – Regulatory and effector T cells display a different profile of histamine production and histamine receptors expression 
Massimo Costanza– Silvia Musio – Rosetta Pedotti
Neurological Institute Foundation Irccs C. Besta, Department Of Clinical Neuroscience, Milan, Italy

127 – Granulocytic myeloid derived suppressor cells modulate central nervous system inflammation during experimental autoimmune encephalomyelitis and attenuate optic nerve atrophy
Benjamin Knier (1) – Michael Hiltensperger (2) – Christopher Sie (2) – Lilian Aly (1) – Uwe Koedel (3) – Bernhard Hemmer (4) – Thomas Korn (1) 
Department Of Neurology / Department Of Experimental Neuroimmunology, Klinikum Rechts Der Isar, Technical University Munich, Munich, Germany (1) – Department Of Experimental Neuroimmunology, Klinikum Rechts Der Isar, Technical University Munich, Munich, Germany (2) – Department Of Neurology, Klinikum Grosshadern, Ludwig-maximillians-universität München, Munich, Germany (3) – Department Of Neurology, Klinikum Rechts Der Isar, Technical University Munich, Munich, Germany (4) 

129 – Increased Granulocyte-Macrophage Colony-Stimulating Factor Expression by Immune Cells in Multiple Sclerosis 
Cris Constantinescu – Jehan Aram – Bruno Gran
University Of Nottingham, Neuroscience, Nottingham, United Kingdom

132 – Understanding the role of pathogenic CD8 positive T cells in a novel mouse model of multiple sclerosis
Prenitha Mercy Ignatius Arokia Doss (1) – Ana C Anderson (2) – Manu Rangachari (1)
Centre Hospitalier De L’université Laval (chul), Laval University, Quebec City, Canada (1) – Brigham And Women’s Hospital, Harvard Medical School, Boston, United States (2) 

138 – A unique TGFbeta-1-driven genomic program links astrocytosis, low-grade inflammation and chronic demyelination in the spinal cord of multiple sclerosis patients
Serge Nataf (1) – Catherine Grego (2) – Laurent Pays (3) 
University Lyon-1, Hospices Civils De Lyon (hcl), Inserm 1060, Bank Of Tissues And Cells, Lyon, France (1) – University Lyon-1, Ufr Lyon Est, Lyon, France (2) – University Lyon-1, Inserm 1060, Carmen Laboratory, Lyon, France (3) 

140 – Defining the role of NG2 in CNS inflammation 
Maja Kitic (1) – Khalad Karram (1) – Nicole Israel (1) – Jan Bauer (2) – Florian C. Kurschus (1) – Ari Waisman (1) 
Institute For Molecular Medicine, University Medical Center Of The Johannes Gutenberg University Mainz, Mainz, Germany (1) – Department Of Neuroimmunology, Center For Brain Research, Medical University Of Vienna, Vienna, Austria (2) 

153 – ROS-initiated calcium-influx drives axonal degeneration in an animal model of multiple sclerosis
Maarten E. Witte (1) – Adrian-Minh Schumacher (1) – Christoph Mahler (1) – Jan Bewersdorf (1) – Philip R. Williams (2) – Oliver Griesbeck (3) – Thomas Misgeld (2, 4, 5)* – Martin Kerschensteiner (1, 4)* 
Institute of Clinical Neuroimmunology, Ludwig-Maximilians University, Munich, Germany (1)  Institute of Neuronal Cell Biology, Technische Universität München, Munich, Germany (2) – Max Planck Institute of Neurobiology, Martinsried, Germany (3) – Munich Cluster for Systems Neurology (SyNergy), Munich, Germany (4) – German Center for Neurodegenerative Diseases (DZNE), Munich, Germany (5) 
* These authors contributed equally to this work. 

157 – Mimetic nerve growth factor tropomyosin receptor kinase A agonist non peptide molecule treats acute and chronic experimental autoimmune encephalomyelitis 
Elena Bonechi (1) – Antonio Sibilla (1) – Alessandra Aldinucci (1) – Luca Massacesi (1) – Federico Cozzolino (2) – Clara Ballerini (1) 
University Of Florence, Dipartimento Di Neuroscienze Psicologia Area Del Farmaco E Salute Del Bambino, Firenze, Italy (1) – University Of Florence, Dipartimento Di Scienze Biomediche, Sperimentali E Cliniche “Mario Serio”, Firenze, Italy (2) 

159 – Type I interferon signaling modulates antibody-mediated demyelination Carsten Tue Berg (1) – Reza Khorooshi (1) – Chris Linington (2) – Nasrin Asgari (1)Trevor Owens (1) 
University Of Southern Denmark, Dept. Neurobiology, Institute Of Molecular Medicine, Odense C, Denmark (1) – University Of Glasgow, Glasgow Biomedical Research Centre, Glasgow, United Kingdom (2) 

163 – Innate glial interferons regulate CNS inflammation 
Ruthe Dieu – Reza Khorooshi – Anne Mariboe – Marie-louise Hyre Arpe – Trevor Owens Institute Of Molecular Medicin, Neurobiology Research, University Of Southern Denmark, Odense, Denmark

170 – Proliferation and activation state of T cells in Multiple Sclerosis Lesions Joana Machado-Santos (1) – Etsuji Saji (2)Jan Bauer (1) – Hans Lassmann (1) 
Center For Brain Research, Medical University Of Vienna, Vienna, Austria (1) – Brain Research Institute, Niigata University, Niigata, Japan (2) 

182 – Integrative transcriptomics and proteomics analysis reveals a potential role for serpina3n and s100A4 in the neurodegeneration process during experimental autoimmune encephalomyelitis
Nicolas Fissolo (1) – Berta Miró (2) – Clara Matute-Blanch (1) – Sunny Malhotra (1) – Alex Sanchez (2) – Shohreh Issazadeh-Navikas (3) – Xavier Montalban (1) – Manuel Comabella (1) 
Cemcat, Multiple Sclerosis Centre Of Catalonia, Clinical Neuroimmunology Unit, Research Institut – Vall D’hebron University Hospital, Barcelona, Spain (1) – Unitat D’estadística I Bioinformática, Vall D’hebron Institut De Recerca (vhir), Barcelona, Spain (2) – Biotech Research And Innovation Centre (bric), University Of Copenhagen, Copenhagen, Denmark (3) 

188 – Importance of very late antigen 4 and melanoma cell adhesion molecule for the CNS infiltration of encephalitogenic CD4+ T cells 
Johanna Breuer (1) – Tilman Schneider-Hohendorf (1) – Sebastian Herich (1) – Ken Flanagan (2) – Tanja Kuhlmann (3) – Heinz Wiendl (1) – Nicholas Schwab (1) 
Department Of Neurology, University Clinic Of Muenster, Münster, Germany (1) – Prothena Inc, Prothena Inc, South San Francisco, United States (2) – Department Of Neuropathology, University Clinic Of Muenster, Münster, Germany (3) 

191 – Modulation of monocytes by bioactive lipid anandamide in multiple sclerosis involves distinct Toll-like receptors
Alessandro Leuti (1) – Valerio Chiurchiù (1) – Maria Teresa Cencioni (2) – Diego Centonze (3) – Maria Albanese (4) – Marco De Bardi (1) – Luca Battistini (1) – Mauro Maccarrone (5) 
Irccs Santa Lucia Foundation, European Center For Brain Research (cerc), Rome, Italy (1) – Centre For Neuroscience, Wolfson Neuroscience Laboratories, Imperial College, Department Of Medicine, Division Of Brain Sciences, London, United Kingdom (2) – Irccs Istituto Neurologico Mediterraneo (inm), Neuromed Pozzilli, Rome, Italy (3) – University Tor Vergata Of Rome,, Clinica Neurologica, Dipartimento Di Medicina Dei Sistemi, Rome, Italy (4) – Campus Bio-medico University Of Rome, School Of Medicine And Center Of Integrated Research, Rome, Italy (5) 

202 – Expression of IL-1beta in rhesus EAE and MS lesions is mainly induced in the CNS itself 
Saskia Burm (1) – Laura Peferoen (2) – Ella Zuiderwijk-Sick (1) – Krista Haanstra (3) – Bert ‘t Hart (3) – Paul Van Der Valk (2) – Sandra Amor (2) – Jan Bauer (4)Jeffrey Bajramovic (1) 
Biomedical Primate Research Centre, Alternatives, Rijswijk, Netherlands (1) – Vu Medical Center, Department Of Pathology, Amsterdam, Netherlands (2) – Biomedical Primate Research Centre, Immunobiology, Rijswijk, Netherlands (3) – Medical University Of Vienna, Department Of Neuroimmunology, Vienna, Austria (4) 

204 – The signaling strength of PI3-Kinase determines pathogenicity of T helper cells in autoimmunity
Sonja Moos (1) – Daniele Ielo (1) – Florian Wanke (1) – Stephanie Graef (1) – André P. Heinen (1) – Morad Zayoud (1) – Khalifa El Malki (1) – Katrin Frauenknecht (2) – Sonja Reissig (1) – Jean-Christophe Renauld (3) – Klaus Rajewsky (4) – Ari Waisman (1) – Florian C. Kurschus (1) 
Institute For Molecular Medicine, University Medical Center Of The Johannes Gutenberg-university Mainz, Mainz, Germany (1) – Department Of Neuropathology, University Medical Center Of The Johannes Gutenberg-university Mainz, Germany, – (2) – Ludwig Institute For Cancer Research, Université Catholique De Louvain, Brussels, Belgium (3) – Immune Disease Institute, Harvard Medical School, Boston, United States (4) 

219 – Microvesicles as a possible biomarker for microglia activation in vivo during phases of disease activity in Multiple Sclerosis and their correlation with different stages of disease course 
Tommaso Croese (1) – Marco Pisa (1) – Annamaria Finardi (2) – Vittorio Martinelli (1) – Giancarlo Comi (1) – Roberto Furlan (2) 
San Raffaele Hospital, Department Of Neurology, Milan, Italy (1) – San Raffaele Hospital, Department Of Clinical Neuroimmunology, Milan, Italy (2) 

226 – Genome-wide analysis reveals a unique transcriptional signature regulated by interleukin-1beta during differentiation of T helper 17 cells Elisabetta Volpe (1) – Manuela Bianco (1, 2) – Chiara Naro (2) – Alessia Capone (1, 2) – Marco De Bardi (1) – Luca Battistini (1) – Claudio Sette (2) 
Neuroimmunology Unit, Santa Lucia Foundation, Rome, Italy (1) – Neuroembriology Unit, Santa Lucia Foundation, Rome Italy and Dept. of Biomedicine and Prevention, University of Rome Tor Vergata. (2) 

227 – Role of Toll-like receptor 2 in mediating infection and inflammation in Multiple Sclerosis 
MD Jakir Hossain (1) – Elena Morandi (1) – Radu Tanasescu (1)Cris S. Constantinescu (1) – Tola A. Faraj (2) – Clett Erridge (2) – Bruno Gran (1) 
University Of Nottingham, Division Of Clinical Neuroscience, School Of Medicine, Queen’s Medical Centre, NG7 2UH, Nottingham, United Kingdom (1) – University Of Leicester, Department Of Cardiovascular Sciences, Clinical Sciences Wing, Glenfield General Hospital, LE3 9QP, Leicester, United Kingdom (2) 

233 – Molecular mechanisms underlying the pathogenic function of IL-23 in autoimmune neuroinflammation
Melania Balzarolo (1) – Andrew L Croxford (1) – Tom Hartwig (1) – Pawel Pelczar (2) – Burkhard Becher (1) 
Institute Of Experimental Immunology, University Of Zurich, Zurich, Switzerland (1) – Center For Transgenic Models, University Of Basel, Basel, Switzerland (2) 

238 – miR-155-3p and heat shock protein 40 genes regulate T helper cell 17 development during autoimmune demyelination 
Marcin P. Mycko – Maria Cichalewska- Hanna Cwiklinska – Krzysztof W. Selmaj
Medical University Of Lodz, Department Of Neurology, Laboratory Of Neuroimmunology, Lodz, Poland

241 – Loss of oligodendrocyte connexins aggravates experimental autoimmune encephalomyelitis
Kleopas Kleopa (1) – Christos Papaneophytou (1)Elena Georgiou (1) – Irene Sargiannidou (1) – Charles Abrams (2) 
The Cyprus Institute Of Neurology And Genetics, The Cyprus School Of Molecular Medicine, Neuroscience Laboratory And Neurology Clinics, Nicosia, Cyprus (1) – The University Of Illinois At Chicago, Neurology And Rehabilitation, College Of Medicine, Chicago, United States (2) 

251 – Dysregulation of regulatory CD56bright NK cells/T cells interactions in multiple sclerosis
Alice Laroni (1)Eric Armentani (1) – Nicole Kerlero De Rosbo (1) – Federico Ivaldi (1) – Emanuela Marcenaro (2) – Simona Sivori (2) – Roopali Gandhi (3) – Howard L. Weiner (3) – Alessandro Moretta (2) – Giovanni L. Mancardi (1) – Antonio Uccelli (1)
University Of Genova, Department Of Neuroscience, Rehabilitation, Ophthalmology, Genetics, Maternal And Child Health, Genova, Italy (1) – University Of Genova, Department Of Experimental Medicine, Genova, Italy (2) – Brigham And Women’s Hospital And Harvard Medical School, Ann Romney Center For Neurologic Diseases, Boston, United States (3) 

257 – IRF4 but not ROR-gammat is indispensable for pathogenic Th17 cell development and maintenance 
Ilgiz Mufazalov (1) – Laureen Gabriel (1) – Christopher Hackenbruch (1) – Tommy Regen (1) – Janina Kuschmann (1) – Florian Wanke (1) – Nir Yogev (1) – Ulf Klein (2) – Dan Littman (3) – Tobias Bopp (4) – Florian Kurschus (1) – Ari Waisman (1) 
Institute For Molecular Medicine, Jg University Mainz, Mainz, Germany (1) – Herbert Irving Comprehensive Cancer Center, Columbia University, New York, United States (2) – The Kimmel Center For Biology And Medicine Of The Skirball Institute And The Howard Hughes Medical Institute, New York University School Of Medicine, New York, United States (3) – Institute For Immunology, Jg University Mainz, Mainz, Germany (4) 

262 – The role of integrins in the control of Th1 and Th17 cell dynamics in the central nervous system during experimental autoimmune encephalomyelitis
Silvia Dusi – Barbara Rossi – Stefano Angiari – Tommaso Carlucci – Gabriela Constantin University Of Verona, Department Of Medicine, Verona, Italy

265 – Inhibition of hyaluronan synthesis using 4-methylumbelliferone restores immune tolerance in CNS autoimmunity
Hedwich F. Kuipers (1) – Mary Rieck (1) – Irina Gurevich (2) – Nadine Nagy (1) – Manish Butte (2) – Thomas Wright (3) – Lawrence Steinman (4) – Paul Bollyky (1) 
Stanford University, Medicine, Stanford, CA, United States (1) – Stanford University, Pediatrics, Stanford, CA, United States (2) – Benaroya Research Institute, Matrix Biology Program, Seattle, WA, United States (3) – Stanford University, Neurology and Neurological Sciences, Stanford, CA, United States (4) 

277 – Phosphorylation of alphaB-crystallin supports reactive astrogliosis in demyelination 
Hedwich F. Kuipers (1) – Jane Yoon (1) – Johannes Winderl (1) – Jack Van Horssen (2) – May Han (1) – Theo Palmer (3) – Lawrence Steinman (1) 
Stanford University, Neurology and Neurological Sciences, Stanford, CA, United States (1) – VU University Medical Center, Molecular Cell Biology and Immunology, Amsterdam, Netherlands (2) – Stanford University, Neurosurgery, Stanford, CA, United States (3) 

278 – FoxP3+ regulatory T cells use heparanase to strip IL-2 from the extracellular matrix at sites of autoimmune inflammation
Hedwich F. Kuipers (1) – Ben Falk (2) – Kathleen Braun (2) – Michael Kinsella (2) – Israel Vlodavsky (3) – Gerald Nepom (4) – Thomas Wight (2) – Paul Bollyky (1) 
Stanford University, Medicine, Stanford, CA, United States (1) – Benaroya Research Institute, Matrix Biology Program, Seattle, WA, United States (2) – Technion-Israel Institute of Technology, Cancer & Vascular Biology Research Center, Haifa, Israel (3) – Benaroya Research Institute, Diabetes Research Program, Seattle, WA, United States (4) 

266 – IL-17 differentially modulates CNS autoimmunity in a cell type-specific way 
Tommy Regen – Judith Hauptmann – Ari Waisman
University Medical Center Of The Johannes Gutenberg University, Institute For Molecular Medicine, Mainz, Germany

276 – Defective Induction of Tolerogenic Myeloid DCs by IL-27 in Relapsing MS encompass multiple immune check points molecules
Felipe Von Glehn – Gopal Murugayan – Keren Regev – Vanessa Beynon – Chantal Kuhn – Maria Antonietta Mazzola – Sushrut Jangi – Pia Kivisakk – Roopali Gandhi – Howard Weiner – Clare Baecher-Allan
Brigham And Women’s Hospital, Harvard Medical School/ Department Of Neurology, Boston, United States

295 – Priming of pathogenic lymphocytes: Role of CCR2+ Ly6Chi Monocytes Ana Amorim – Andrew L. Croxford – Sarah Mundt – Burkhard Becher
Institute Of Experimental Immunology, University Of Zürich, Zurich, Switzerland

296 – Epigenomic changes in monocytes from MS patients with high Body Mass Index and related murine EAE model
Kamilah Castro (1) – Maria Petracca (2) – Yunjiao Zhu (1) – Mar Gacias (1) – Corey T Watson (1) – Peter Kosa (3) – Tamjeed Sikder (1) – Jessica Zhang (1) – Payal Naik (1) – Yadira Bencosme (2) – Shelly Phelps (2) – Michael Kiebish (4) – Andrew Sharp (1) – Bibi Bielekova (3)Matilde Inglese (2) – Ilana Katz Sand (2) – Patrizia Casaccia (1) 
Icahn School Of Medicine At Mount Sinai, Neuroscience, New York, United States (1) – Icahn School Of Medicine At Mount Sinai, Neurology, New York, United States (2) – National Institute Of Neurological Disorders And Stroke, Neurology, Bethesda, United States (3) – Berg Health, Inc, Neurology, Framingham, United States (4) 

297 – The gateway reflexes, novel neuro-immune interactions, are critical for the development of mouse models of multiple sclerosis 
Daisuke Kamimura – Yasunobu Arima – Andrea Stofkova – Naoki Nishikawa – Yukihiro Sakashita – Kotaro Higuchi – Takuto Ohki – Masaaki Murakami
Molecular Neuroimmunology, Institute For Genetic Medicine, Graduate School Of Medicine, Hokkaido University, Sapporo, Japan

300 – B Cells from Blood of Patients with Relapsing Remitting Multiple Sclerosis Induce Death in Human and Rat Neurons
Robert Lisak (1) – Liljana Nedelkoska (1) – Hanane Touil (2) – Joyce Benjamins (1) – Rui Li (2)Amit Bar-Or (2) 
Department Of Neurology, Wayne State University School Of Medicine, Detroit, Mi, United States (1) – Department Of Neurology, Mcgill University, Montreal, Canada (2) 

301 – Micromilieu CNS requirements for the induction of a CD8 T cell-mediated attack on oligodendrocytes 
Monica Sanchez-Ruiz (1) – Noelle K. Polakos (2) – Tobias Blau (1) – Sandra Maier (1) – Thomas Hünig (2)Martina Deckert (1) 
Department Of Neuropathology, University Hospital Of Cologne, Cologne, Germany (1) – Institute For Virology And Immunobiology, University Of Würzburg, Würzburg, Germany (2) 

304 – Bone morphogenetic protein signaling as a potential therapeutic target for multiple sclerosis
Herena Eixarch (1, 2) – Laura C. Barreiro (1, 2) – Mireia Castillo (1, 2) – Ana Gutierrez-Franco (1, 2) – Vanessa Gil (3, 4, 5, 6) – Jose Antonio Del Río (3, 4, 5, 6) – Xavier Montalban (1, 2)Carmen Espejo (1, 2) 
Servei de Neurologia-Neuroimmunologia, Centre d’Esclerosi Múltiple de Catalunya, Vall d’Hebron Institut de Recerca, Hospital Universitari Vall d’Hebron, Barcelona, Spain (1) – Universitat Autònoma de Barcelona, 08193 Bellaterra (Cerdanyola del Vallès), Spain (2) – Molecular and Cellular Neurobiotechnology, Institute for Bioengineering of Catalonia (IBEC), Parc Científic de Barcelona, Barcelona, Spain (3) – Department of Cell Biology, Physiology and Immunology, Universitat de Barcelona, Barcelona, Spain (4) – Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas (CIBERNED), Barcelona, Spain (5) – Institut de Neurociències Universitat de Barcelona, Barcelona, Spain (6) 

307 – Immunoglobulins G with oxidoreductase activity of patients with schizophrenia and multiple sclerosis 
Lev Sinianskii (1) – Liudmila Smirnova (2) – Nina Krotenko (1) – Irina Mednova (1) – Evgeniy Ermakov (3) – Marina Titova (4) – Valentina Alifirova (4) – Arkadiy Semke (2) – Svetlana Ivanova (2) 
Mental Health Research Institute, Siberian State Medical University, Tomsk, Russian Federation (1) – Mental Health Research Institute, Laboratory Of Molecular Genetics And Biochemistry, Tomsk, Russian Federation (2) – Novosibirsk State University, Department Of Molecular Biology, Novosibirsk, Russian Federation (3) – Siberian State Medical University, Department Of Neurology And Neurosurgery, Tomsk, Russian Federation (4) 

332 – Amelioration of neuroinflammation by the alpha 7 nicitinic acetylcholine receptor allosteric agonist and positive allosteric modulator GAT107
Tehila Mizrachi (1) – Karen Bursin (1) – Yael Ben-David (2) – Abhijit R. Kulkarni (3) – Thakur A. Ganesh (3) – Adi Vaknin (1) – Millet Treinin (2)Talma Brenner (1) 
Hadassah Medical Center, Neurology, Jerusalem, Israel (1) – Hebrew University Medical School, Medical Neurobiology, Jerusalem, Israel (2) – School Of Pharmacy, Northeastern University, Pharmaceutical Sciences, Boston, United States (3) 

354 – Factor X inhibition ameliorates experimental autoimmune encephalomyelitis 
Monika Merker (1) – Susann Pankratz (1) – Alexander Herrmann (1) – Heinz Wiendl (1) – Christoph Kleinschnitz (2) – Kerstin Göbel (1) – Sven G. Meuth (1) 
Department Of Neurology, University Hospital Muenster, Muenster, Germany (1) – Department Of Neurology, University Hospital Wuerzburg, Wuerzburg, Germany (2) 

355 – The nuclear receptor Nur77 restricts T cell responses and limits central nervous system autoimmunity
Marie Liebmann (1) – Stephanie Hucke (1) – Tanja Kuhlmann (2) – Heinz Wiendl (1) – Luisa Klotz (1) 
Department Of Neurology, University Hospital Muenster, Muenster, Germany (1) – Institute For Neuropathology, University Of Muenster, Muenster, Germany (2) 

367 – Delayed onset and reduced disease severity of spontaneous central nervous system autoimmunity by conjugated linoleic acid-rich diet 
Stephanie Hucke (1) – Marvin Hartwig (1)Ann-Katrin Fleck (1) – Matrin Herold (1) – Kerstin Berer (2) – Marie Liebmann (1) – Ivan Kuzmanov (1) – Berit Grützke (1) – Angelos Sagredos (3) – Maria Eveslage (4) – Catharina C. Gross (1) – Gurumoorthy Krishnamoorthy (2) – Tanja Kuhlmann (5) – Heinz Wiendl (1) – Luisa Klotz (1) 
Department Of Neurology, University Of Muenster, Muenster, Germany (1) – Department Of Neuroimmunology, Max Planck Institute Of Neurobiology, Martinsried, Germany (2) – Trofocell Research And Trade GmbH, Trofocell Research And Trade Gmbh, Hamburg, Germany (3) – Institute Of Biostatistics And Clinical Research, University Of Muenster, Muenster, Germany (4) – Department Of Neuropathology, University Of Muenster, Muenster, Germany (5) 

382 – Electrophysiological brain networks in patients with Multiple Sclerosis: an exploratory study TMS-EEG study
Vasilios K Kimiskidis (1) – Vasilios Papaliagkas (1) – Zoi Kouvatsou (2) – Elvira Masoura (2) – Christos Koutlis (3) – Elsa Siggiridou (3) – Maria Karagianni (2) – Georgia Zafeiridou (1) – Maria-Heleni Kosmidis (2) – Grigorios Kioseoglou (2) – Dimitris Kugiumtzis (3) 
Laboratory of Clinical Neurophysiology, AHEPA University Hospital, Thessaloniki, Thessaloniki 54124, Greece (1) – Department of Psychology, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece (2) – Department of Electrical and Computer Engineering, Aristotle University of Thessaloniki, Thessaloniki 54124, Greece (3) 

384 – Chondroitin sulfate proteoglycans in perivascular cuffs: A novel mediator of neuroinflammation in multiple sclerosis 
Erin Stephenson – Manoj Mishra – Daniel Moussienko – V. Wee Yong
University of Calgary, Canada

The Role of B Cells and B-Cell, Targeting Treatment in MS (and other Neuroimmune disease-revisited)

21 – Intra-thecal methotrexate therapy for progressive multiple sclerosis: the effect on disability cognition and cerebrospinal fluid cellular and antibodies content
Karin Mausner-Fainberg (1) – Hadar Kolb (1) – Keren Regev (1) – Moran Penn (1, 2) – Meir Kestenbaum (1) – Avi Gadoth (1)Arnon Karni (1, 2) 
Neuroimmunology Laboratory, Department of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel (1) – Sackler’s Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel (2) 

24 – B cell-derived IL-10 regulates pro-inflammatory activity of myeloid cells in a clinically meaningful manner 
Sebastian Torke – Silke Kinzel – Wolfgang Brück – Martin S Weber
Institute Of Neuropathology, University Medical Center, Goettingen, Germany

25 – Enrichment of B cells with pro-inflammatory properties following anti-CD20 mediated B cell depletion in an EAE model actively involving B cells
Linda Feldmann (1) – Claude C.A. Bernard (2) – Wolfgang Brück (1) – Martin S. Weber (1) 
Neuropathology Göttingen, University Medical Center Göttingen, Göttingen, Germany (1) – Monash Immunology And Stem Cell Laboratories,, Monash University, Monash, Australia (2) 

26 – In vivo dimethyl fumarate treatment enhances the ability of B cells to present antigen 
Sarah Traffehn – Imke Metz – Wolfgang Brück – Martin S. Weber
Department Of Neuropathology, University Medical Center, Göttingen, Germany

56 – ALCAM regulates B cells migration across the barriers of the CNS
Laure Michel (1) – Camille Grasmuck (1) – Evelyn Peelen (1) – Marc Charabati (1) – Marc-André Lécuyer (1) – Lyne Bourbonnière (1) – Sandra Larouche (1) – Pierre Duquette (1) – Amit Bar-Or (2) – Jennifer Gommerman (3)Alexandre Prat (1) 
Crchum, Univeristé De Montréal, Montréal, Canada (1) – Department Of Neurologu, Mcgill University, Montréal, Canada (2) – Department Of Immunology, University Of Toronto, Toronto, Canada (3) 

131 – CNS-derived APRIL triggers IL-10 production from astrocytes in multiple sclerosis 
Patrice Lalive (1) – Laurie Baert (2) – Natalia Popa (3) – Madhia Benkhoucha (1) – Benoit Manfroi (2) – Jean Boutonnat (4) – Gilda Raguenez (3) – Marine Tessier (3) – Fabienne Pelletier (3) – Pascal Schneider (5) – Olivier Casez (6) – Romain Marignier (7) – Patrice Marche (2) – Michael Hahne (8) – Dominique Baeten (9) – Hans Lassmann (10) – Jose Boucraut (3)Bertrand Huard (2) 
Neurology, University Hospital, Geneva, Switzerland (1) – Institute For Advanced Biosciences, University Grenoble Alpes/INSERM, La Tronche, France (2) – Université Méditerrannée, Faculty Of Medicine, Marseille, France (3) – DACP, University Hospital, Grenoble, France (4) – Biochemistry, University, Lausanne, Switzerland (5) – Neurology, University Hospital, Grenoble, France (6) – Neurosciences Research Centre, Faculty Of Medicine, Lyon, France (7) – Molecular Genetics, CNRS, Montpellier, France (8) – Academic Medical Center, University, Amsterdam, the Netherlands (9) – Brain Research, University, Vienna, Austria (10) 

168 – Dysregulation of B lymphocytes in Myalgic encephalomyelitis/Chronic Fatigue Syndrome
Wakiro Sato – Hirohiko Ono – Masakazu Nakamura – Takashi Yamamura
Department of Immunology, National Institute of Neuroscience, National Center of Neurology and Psychiatry (NCNP)

169 – Fingolimod therapy promotes a B cell-mediated anti-inflammatory cytokine profile in B and T cells and reduces CXCR4-mediated B cell migration in patients with Multiple Sclerosis
Shiri Blumenfeld (1) – Elsebeth Staun-Ram (1) – Ariel Miller (2) 
Rappaport Faculty Of Medicine, Technion- Israel Institute Of Technology, Haifa, Israel (1) – Neuroimmunology Unit & Multiple Sclerosis Center, Carmel Medical Center, Haifa, Israel (2) 

172 – Long-lived plasma cells can persist in the central nervous system during chronic neuroinflammation 
Karolin Pollok (1)Ronja Mothes (2) – Friedemann Paul (3) – Alina Liebheit (4) – Carolin Ulbricht (4) – Anja Hauser (5) – Helena Radbruch (2) 
Deutsches Rheumaforschungszentrum, Ag Immune Dynamics, Berlin, Germany (1) – Charité – Universitätsmedizin Berlin, Department Of Neuropathology, Berlin, Germany (2) – Charité – Universitätsmedizin Berlin, Neuro Cure, Berlin, Germany (3) – Deutsches Rhemaforschungszentrum Berlin, Ag Immune Dynamics, Berlin, Germany (4) – Charité – Universitätsmedizin Berlin, Division Of Rheumatology And Clinical Immunology, Berlin, Germany (5) 

185 – Dimethyl Fumarate therapy modulates B cells phenotype and functional markers, increasing IL10+ B regulatory cell subsets in patients with Multiple Sclerosis 
Elsebeth Staun-Ram (1) – Eiman Najjar (1) – Ariel Miller (1, 2) 
Technion-Israel Institute Of Technology, Rappaport Faculty Of Medicine/Neuroimmunology, Haifa, Israel (1) – Neuroimmunology Unit & Multiple Sclerosis Center, Carmel Medical Center, Haifa, Israel (2) 

249 – Peripheral VH4+ plasmablasts are expanded and demonstrate autoreactivity towards brain antigens in early Multiple Sclerosis patients Nancy Monson (1) – Jacqueline Rivas (2) – Sara Ireland (2) – Rati Chkheidze (3) – Denise Ramirez (2) – Benjamin Greenberg (2) – Lindsay Cowell (4) – Ann Stowe (2) 
Ut Southwestern Medical Center, Neurology And Neurotherapeutics, Dallas, United States (1) – Ut Southwestern Medical Center, Neurology And Neurotherapeutics, Dallas, United States (2) – Ut Southwestern Medical Center, Pathology, Dallas, United States (3) – Ut Southwestern Medical Center, Clinical Sciences, Dallas, United States (4) 

267 – Characterization of local B-cell populations in paired blood and brain compartments in end-stage multiple sclerosis 
Malou Janssen (1) – Gijsbert P. Van Nierop (2) – Georges M. G. M. Verjans (3) – Marvin M. Van Luijn (4) – Rogier Q. Hintzen (1) 
Erasmus MC, Departments Of Immunology And Neurology, MS Center ErasMS, Rotterdam, – (1) – Erasmus MC, Departments Of Neurology And Viroscience, MS Center ErasMS, Rotterdam, Netherlands (2) – Erasmus MC, Department Of Viroscience, Rotterdam, Netherlands (3) – Erasmus MC, Department Of Immunology, MS Center ErasMS, Rotterdam, Netherlands (4) 

324 – Targeting plasma cells with proteasome inhibitors for treatment of myasthenia gravis
Marina Damas (1) – Abi Saxena (1) – Gisela Nogales (2) – Maarten Beek (1) – Nienke Van Den Hoogen (1) – Peter Molenaar (1) – Bert Joosten (1) – Nick Willcox (3) – Pilar Martinez-Martinez (1) – Mario Losen (1) 
Maastricht University, Psychiatry And Neurospychology, Maastricht University, Maastricht, The Netherlands, Maastricht, Netherlands (1) – Germans Trias I Pujol Research Institute And Campus Can Ruti, Au, Translational Research Laboratoy In Neuromuscular Diseases, Neurosciences Department, Badalona, Spain (2) – Nuffield Department Of Clinical Neurosciences, Weatherall Institute For Molecular Medicine, University Of Oxford, Oxford, United Kingdom (3) 

336 – Distinct oligoclonal band antibodies in multiple sclerosis recognize ubiquitous self-proteins
Simone M. Brändle (1) – Birgit Obermeier (1) – Makbule Senel (2) – Jessica Bruder (1) – Reinhard Mentele (1) – Mohsen Khademi (3) – Tomas Olsson (3) – Hayrettin Tumani (2) – Wolfgang Kristoferitsch (4) – Friedrich Lottspeich (5) – Hartmut Wekerle (6) – Reinhard Hohlfeld (1) – Klaus Dornmair (1) 
Institute Of Clinical Neuroimmunology, Ludwig-Maximilians-University, Munich, Germany (1) – Department Of Neurology, University Of Ulm, Ulm, Germany (2) – Neuroimmunology Unit, Department Of Clinical Neuroscience, Center For Molecular Medicine, Karolinska University Hospital, Stockholm, Sweden (3) – Karl Landsteiner Institute For Neuroimmunological And Neurodegenerative Disorders, Sozialmedizinisches Zentrum Donauspital, Vienna, Austria (4) – Department Of Protein Analystics, Max-Planck Institute Of Biochemistry, Martinsried, Germany (5) – Department Of Neuroimmunology, Max-Planck Institute Of Neurobiology, Martinsried, Germany (6) 

Personalized Neuroimmunology / Genetic and Immune Biomarkers to Individualize Diagnosis and Treatment in Neuroimmunology

38 – Establishing the role of miR-150 in Multiple Sclerosis and experimental autoimmune encephalomyelitis
Eliane Piket (1) – Lara Kular (1) – William Nyberg (2) – Alexander Espinosa (2) – Fredrik Piehl (1) – Maja Jagodic (1) 
Karolinska Institute, Dept. Of Clinical Neuroscience, Karolinska University Hospital, Stockholm, Sweden (1) – Karolinska Institute, Dept. Of Medicine, Karolinska University Hospital, Stockholm, Sweden (2) 

62 – Molecular profiling of damage and repair in the CSF by translating transcriptome data to CSF proteome 
Nellie Anne Martin (1) – Arkadiusz Nawrocki (1) – Martin Røssel Larsen (2) – Viktor Molnar (3) – Peter Acs (4) – Miklos Palkovits (5) – Finn Sellebjerg (6) – Zoltan Hegedus (7) – Nicolas Alcaraz (8) – Eudes Barbosa (8) – Jan Baumback (8) – Zsolt Illes (1) 
Department Of Neurology, Odense University Hospital And Institute Of Clinical Research, Odense, Denmark (1) – Department Of Biochemistry And Molecular Biology, University Of Southern Denmark, Odense, Denmark (2) – Department Of Genetics, Cell- And Immunobiology, Semmelweis University, Budapest, Hungary (3) – Department Of Neurology, University Of Pecs, Pecs, Hungary (4) – Department Of Anatomy, Histology And Embryology, Semmelweis University, Budapest, Hungary (5) – Department Of Neurology, Rigshospitalet And University Of Copenhagen, Copenhagen, Denmark (6) – Laboratory Of Bioinformatics, Biological Research Centre, Szeged, Hungary (7) – Department Of Mathematics And Computer Science, University Of Southern Denmark, Odense, Denmark (8) 

64 – Genotype is predicting Multiple Sclerosis pathology in the cohort of the Netherlands Brain Bank
Nina Louise Fransen (1) – Matthew Mason (2) – Bart Crusius (3) – Corbert Van Eden (1) – Mark Mizee (1) – Sabina Luchetti (1) – Inge Huitinga (1) 
Netherlands Institute Of Neuroscience, Neuroimmunology, Amsterdam, Netherlands (1) – Netherlands Institute Of Neuroscience, Neuroregeneration, Amsterdam, Netherlands (2) – Vu University Medical Centre, Immunogenetics, Amsterdam, Netherlands (3) 

93 – Differential Antibody Responses to Gliadin-derived Indigestible Peptides in Schizophrenia 
Ryan Mclean (1) – Philip Wilson (2) – David St Clair (3) – Colette Mustard (1) – Jun Wei (1) 
University Of The Highlands And Islands, Department Of Health Research, Inverness, United Kingdom (1) – University Of Aberdeen, Centre For Rural Health, Inverness, United Kingdom (2) – University Of Aberdeen, Department Of Dentistry And Medicine, Aberdeen, United Kingdom (3) 

95 – Circulating microRNAs as Biomarkers for rituximab therapy, in Neuromyelitis Optica (NMO)
Adi Vaknin Dembinsky (1) – Chana Sharvit (1) – Livnat Brill (1) – Oded Abramsky (1) – Devorah Wahnon (2) – Iddo Ben Dov (2) – Iris Lavon (1) 
Hadassah Medical Center, Neurology, Jerusalem, Israel (1) – Nephrology And Hypertension Services, Nephrology And Hypertension Services, Jerusalem, Israel (2) 

121 – MMP9 index as possible diagnostic marker of Neuro-Behçet’s disease 
Alessandra Aldinucci (1) – Elena Bonechi (1) – Alessandro Barilaro (2) – Anna Maria Repice (2) – Tiziana Biagioli (3) – Giacomo Emmi (4) – Mario Milco D’Elios (4) – Clara Ballerini (1) 
University Of Florence, Department Of Neurofarba, Florence, Italy (1) – Careggi University Hospital, Division Neurology 2, Florence, Italy (2) – Careggi University Hospital, Laboratory Department, Florence, Italy (3) – University Of Florence, Department Of Experimental And Clinical Medicine, Florence, Italy (4) 

123 – Searching for Dysregulation in Multiple Sclerosis
Sundararajan Srinivasan (1) – Ramesh Menon (2) – Marco Di Dario (2) – Alessandra Russo (2) – Severa Martina (3) – Fabiana Rizzo (3) – Lucia Moiola (4) – Mariaemma Rodegher (4) – Rosella Mechelli (5) – Marzia Romeo (4) – Marta Radaelli (4) – Francesca Sangalli (4) – Paul Hertzog (6) – Marco Salvetti (5) – Eliana Coccia (3) – Vittorio Martinelli (4) – Giancarlo Comi (2) – Cinthia Farina (2) 
Institute Of Experimental Neurology (inspe), Division Of Neuroscience, San Raffaele Scientific Institute,university Vita-salute San Raffaele, Milan, Italy (1) – Institute Of Experimental Neurology (inspe), Division Of Neuroscience, San Raffaele Scientific Institute, Milan, Italy (2) – Istituto Superiore Sanità (iss), Istituto Superiore Sanità (iss), Rome, Italy (3) – Division Of Neuroscience, San Raffaele Scientific Institute, Milan, Italy (4) – Centre For Experimental Neurological Therapies, S. Andrea Hospital-site, Department Of Neuroscience, Mental Health And Sensory Organs (nesmos), Sapienza University Of Rome, Rome, – (5) – Centre For Innate Immunity And Infectious Diseases, Mimr-phi Institute Of Medical Research, Clayton, Victori, Australia (6) 

130 – Clinical characterization of patients with CNS demyelination among the Muslims Arabs population in Israel
Livnat Brill (1) – Oded Abramsky (1) – Tamir Ben Hur (1) – Arnon Karni (2) – Shoshana Israel (3) – Adi Vaknin Dembinsky (1)
Hadassah Medical Center, Neurology, Jerusalem, Israel (1) – Sourasky Medical Center, Neurology, Tel Aviv, Israel (2) – Hadassah Medical Center, Tissue Typing Laboratory, Jerusalem, Israel (3) 

142 – MicroRNA expression levels and variants of microRNA genes as biomarkers of multiple sclerosis clinical course
Olga Kulakova (1) – Natalia Baulina (1) – Ivan Kiselev (1) – Vitalina Bashinskaya (1) – Ekaterina Popova (2) – Alexey Boyko (2) – Olga Favorova (1) 
N.I. Pirogov Russian National Research Medical University, Dep. of Molecular Biology and Medical Biotechnology, Moscow, Russian Federation (1) – N.I. Pirogov Russian National Research Medical University, Dep. of Neurology, Neurosurgery, and Medical Genetics, Moscow, Russian Federation (2) 

220 – Differential genome-wide DNA methylation patterns in peripheral blood mononuclear cells of relapsing-remitting and primary-progressive multiple sclerosis patients
Olga Kulakova (1) – Marsel Kabilov (2) – Ludmila Danilova (3) – Ekaterina Popova (4) – Olga Baturina (2) – Ekaterina Tsareva (1) – Natalia Baulina (1) – Ivan Kiselev (1) – Alexey Boyko (4) – Valentin Vlassov (5) – Alexander Favorov (6) – Olga Favorova (1) 
N.I. Pirogov Russian National Research Medical University, Department of Molecular Biology and Medical Biotechnology, Moscow, Russian Federation (1) – Institute of Chemical Biology And Fundamental Medicine, Siberian Branch of The Russian Academy of Sciences, SB RAS Genomics Core Facility, Novosibirsk, Russian Federation (2) – Johns Hopkins School of Medicine, Department of Oncology, Division of Biostatistics and Bioinformatics, Baltimore, MD, United States (3) – N.I. Pirogov Russian National Research Medical University, Department of Neurology, Neurosurgery, and Clinical Genetics, Moscow, Russian Federation (4) – Institute of Chemical Biology and Fundamental Medicine, Siberian Branch of The Russian Academy of Sciences, Center of New Medical Technology, Novosibirsk, Russian Federation (5) – Vavilov Institute of General Genetics, Laboratory of Systems Biology and Computational Genetics, Moscow, Russian Federation (6) 

181 – Comparative analysis of peripheral blood lymphocytic cell death on multiple sclerosis patients receiving interferon and glatiramer acetate – preliminary results 
Marina Boziki – Roza Lagoudaki – Theano Tatsi – Dimitrios Karacostas – Nikolaos Grigoriadis 
2nd Neurologiccal Department, AHEPA University General Hospital, Aristotle University Of Thessaloniki, Thessaloniki, Greece 

196 – Profiling the autoantibody repertoire in saliva of young athletes to identify early protein markers of traumatic brain injury (TBI)
Elisa Pin (1) – Eni Andersson (1) – Kelsey Mitchell (2) – Nelson Cortes (2) – Shane V. Caswell (2) – Mariaelena Pierobon (2) – Emanuel F. Petricoin (2) – Peter Nilsson (1) 
Scilifelab-kth, School Of Biotechnology, Stockholm, Sweden (1) – George Mason University, Center For Applied Proteomics And Molecular Medicine, Manassas, Virginia, United States (2) 

224 – Anoctamin 2 identified as an autoimmune target in multiple sclerosis 
Peter Nilsson (1) – Burcu Ayoglu (1) – Katarina Tengvall (2) – Ingrid Kockum (2) – Tim Waterboer (3) – Tomas Olsson (2) 
Scilifelab, School Of Biotechnology, Kth – Royal Institute Of Technology, Stockholm, Sweden (1) – Karolinska Institutet, Neuroimmunology Unit, Dept Clinical Neuroscience, Stockholm, Sweden (2) – German Cancer Research Center, German Cancer Research Center, Heidelberg, Germany (3) 

232 – In-depth Immunophenotyping of Newly Diagnosed Relapsing Remitting Multiple Sclerosis Patients and Patients treated with Dimethyl Fumarate Maryam Nakhaei-Nejad (1) – David Barilla (1) – Gregg Blevins (1) – Aaron Hirschfeld (2)Fabrizio Giuliani (1) 
University Of Alberta, Medicine, Edmonton, Canada (1) – Bd Biosciences, Mississauga, Canada (2) 

236 – Serum exosomes profiling reveals a novel biomarkers of multiple sclerosis 
Igor Selmaj – Magdalena Namiecinska – Maria Cichalewska – Grazyna Galazka – Krzysztof W. Selmaj – Marcin P. Mycko 
Medical University Of Lodz, Department Of Neurology, Laboratory Of Neuroimmunology, Lodz, Poland 

288 – An optimized protocol of differential centrifugation isolates quantitatively and qualitatively distinct microvesicle populations
Annamaria Nigro (1) – Alessandro Romano (1) – Annamaria Finardi (1) – Marzia M. Ferraro (2) – Antonio Gaballo (2) – Daniela E. Manno (3) – Angelo Quattrini (1) – Roberto Furlan (1) 
San Raffaele Scientific Institute, Division Of Neuroscience, Institute Of Experimental Neurology, Milano, Italy (1) – Nanotechnology Institute, Cnr Nanotec, Lecce, Italy (2) – Department Of Materials Science, University Of Salento, Lecce, Italy (3) 

291 – MS patients show different CSF leukocyte profile than other inflammatory and non-inflammatory neurological diseases, with characteristic intracellular cytokine production
Carmen Picon (1) – Lucienne Frossard (2) – Susana Sainz De La Maza (2) – Eulalia Rodriguez-Martin (1) – Silvia Medina (1) – Mercedes Espiño (1) – Inmaculada Toboso (1) – Jose Carlos Alvarez-Cermeño (2)Luisa Maria Villar (1) 
Hospital Univeristario Ramón Y Cajal, Immunology Department, Madrid, Spain (1) – Hospital Univeristario Ramón Y Cajal, Neurology Department, Madrid, Spain (2) 

347 – Differential binding of commercial secondary antibodies to human IgG-allotypes 
Anita Krysta – Sudhakar Reddy Kalluri – Zsuzsanna Hracsko – Carina Nowak – Christiane Gasperi – Dorothea Buck – Bernhard Hemmer 
Department Of Neurology, Klinikum Rechts Der Isar, Technische Universität München, Munich, Germany 

349 – A comprehensive evaluation of serum microRNAs as biomarkers in Multiple Sclerosis
Keren Regev (1) – Anu Paul (1) – Brian Healy (2) – Felipe Von Glenn (1) – Camilo Diaz-Cruz (2) – Taha Gholipour (2) – Maria Antonietta Mazzola (1) – Radhika Raheja (1) – Parham Nejad (1) – Bonnie I Glanz (2) – Pia Kivisakk (1) – Tanuja Chitnis (2) – Howard L. Weiner (1)Roopali Gandhi (1) – R R (1) 
Ann Romney Center Of Neurologic Diseases, Brigham And Women’s Hospital, Harvard Medical School, Boston, Ma, United States (1) – Partners Ms Center, Brigham And Women’s Hospital, Harvard Medical School, Boston, Ma, United States (2) 

375 – Gene polymorphisms as modifiers of response to interferon beta 1b in Serbian Multiple Sclerosis population (candidate gene study) 
Maja Živković (1)Aleksandar Pantovic (2) – Ana Kolaković (1) – Ljiljana Stojković (1) – Evica Dinčić (2) – Ranko Raicevic (2) – Smiljana Kostić (2) – Dragan Alavantić (1) – Aleksandra Stanković (1) 
”Vinča” Institute of Nuclear Sciences, Laboratory for Radiobiology and Molecular Genetics, University of Belgrade, Belgrade, Serbia (1) – Military Medical Academy, Neurology clinic, Belgrade, Serbia (2) 

376 – Angiotensin-converting enzyme and angiotensin receptors gene polymorphisms as risk factors for multiple sclerosis 
Maja Živković (1)Aleksandar Pantovic (2) – Ana Kolaković (1) – Ljiljana Stojković (1) – Evica Dinčić (2) – Smiljana Kostić (2) – Dragan Alavantić (1) – Aleksandra Stanković (1) 
”Vinča” Institute of Nuclear Sciences, Laboratory for Radiobiology and Molecular Genetics, University of Belgrade, Belgrade, Serbia (1) – Military Medical Academy, Neurology clinic, Belgrade, Serbia (2) 

380 – Treatment response of multiple sclerosis patients under second – line disease modifying treatment: a single center long term retrospective study 
Marina Boziki – Stylianos Kallivoulos – Christos Bakirtzis – Ioannis Nikolaidis – Eleni Polychroniadou – Dimitrios Karacostas – Nikolaos Grigoriadis 
B’ Neurological Department, Aristotle University of Thessaloniki, AHEPA General Hospital, Thessaloniki, Greece 

Novel Imaging of Visual and Other Pathways as Models for Research and Biomarkers of Neuroinflammation ad Neuroregeneration

11 – In Vivo-Morphology of the Optic Nerve and Retina in Patients with Parkinson’s disease
Irene Gottlob (1) – Anastasia Pilat (1)Rebecca J Mclean (1) – Frank A Proudlock (1) – Gail De Maconachie (1) – Viral Sheth (1) – Yusuf A Rajabally (2)
University Of Leicester, Ulverscroft Eye Unit, Leicester, United Kingdom (1) – School Of Life And Health Sciences, Aston Brain Centre, Aston University, Queen Elizabeth Hospital, University Hospitals Of Birmingham, Birmingham, United Kingdom (2) 

53 – The role of multifocal visual evoked potentials in understanding disability in multiple sclerosis 
Elena H Martinez-Lapiscina (1) – Ana Isabel Tercero-Uribe (1) – Salut Alba-Arbalat (1) – Nuria Sola-Vals (1) – Magi Andorra (1) – Maria Sepulveda (1) – Ana Maria Guerrero-Zamora (1) – Ruben Torres-Torres (2) – Sara Llufriu (1) – Irati Zubizarreta (1) – Yolanda Blanco (1) – Bernardo Sanchez-Dalmau (2) – Albert Saiz (1) – Joan Santamaria (1) – Pablo Villoslada (1) 
Hospital Clinic Of Barcelona – Idibaps, Neurology, Barcelona, Spain (1) – Hospital Clinic Of Barcelona – Idibaps, Ophthalmology, Barcelona, Spain (2) 

264 – Retina atrophy is more prominent in the early phases of multiple sclerosis and is associated with clinical disease activity: a cohort study 
Elena H Martinez-Lapiscina (1) – Hao Yiu (2) – Magi Andorra (1) – Sam Arnow (2) – Andrés Cruz-Herranz (2) – Christian Cordano (2) – Albert Saiz (1) – Pablo Villoslada (1) – Ari J Green (2) 
Hospital Clinic Of Barcelona – Idibaps, Neurology, Barcelona, Spain (1) – University Of California, San Francisco (ucsf), Multiple Sclerosis Center, San Francisco, United States (2) 

118 – Uptake of 18F-FET and 18F-FCH in human glioblastoma T98G cell lines after irradiation with photons or carbon ions 
Francesca Pasi (1) – Federica Eleonora Buroni (2) – Marco Giovanni Persico (2) – Jessica Sani (3) – Lorenzo Lodola (2) – Angelica Facoetti (4) – Franco Corbella (1) – Carlo Aprile (2)Rosanna Nano (3) 
Fondazione Irccs Policlinico San Matteo, Department Of Oncohaematology, Radiotherapy Unit, Pavia, Italy (1) – Fondazione Irccs Policlinico San Matteo, Department Of Oncohaematology, Nuclear Medicine Unit, Pavia, Italy (2) – University Of Pavia, Department Of Biology And Biotechnology “Lazzaro Spallanzani”, Pavia, Italy (3) – Cnao Foundation, Radiobiology Unit, Pavia, Italy (4) 

189 – Intravital imaging of calcium activities in the encephalitogenic T cells during their journey to CNS 
Nikolaos I. Kyratsous (1) – Guokun Zhang (1) – Marija Pesic (1) – Ingo Bartholomäus (2) – Marsilius Mues (2) – Ping Fang (1) – Miriam Wörner (1) – Stephanie Everts (1) – Joachim W. Ellwart (3) – Hartmut Wekerle (2)Naoto Kawakami (1) 
Institute Of Clinical Neuroimmunology, Biomedical Center, Lmu Munich, Martinsried, Germany (1) – Max Planck Institute Of Neurobiology, Neuroimmunology, Martinsried, Germany (2) – Institute For Experimental Hematology, Helmholtz Centre, Munich, Germany (3) 

268 – Investigating mediators of neutrophil recruitment to the brain after cerebral ischemia with near-infrared fluorescence imaging 
Markus Vaas (1) – Gaby Enzmann (2) – Anja Kipar (3) – Ulrich Siler (4) – Kai Licha (5) – Markus Rudin (1) – Britta Engelhardt (2) – Jan Klohs (1) 
University And ETH Zurich, Institute For Biomedical Engineering, Zurich, Switzerland (1) – University Of Bern, Theodor Kocher Institute, Bern, Switzerland (2) – Laboratory for Animal Model Pathology, Institute of Veterinary Pathology, Vetsuisse Faculty, University of Zurich, 8057 Zürich, Switzerland (3) – University Children’s Hospital Zurich And Children`s Research Centre, Division Of Immunology, Zurich, Switzerland (4) – Freie Universität Berlin, Institute Of Chemistry And Biochemistry, Berlin, Germany (5) 

306 – Population receptive field mapping in the visual cortex following peripheral optic neuritis
Peter De Best – Noa Raz – Netta Levin
Neurology Department, Hadassah Hebrew University Medical Center, Jerusalem, Israel 

337 – Retinal axonal loss in relapsing multiple sclerosis is associated with disability and brain tissue damage but not with markers of inflammation
Letizia Leocani – Marco Pisa – Tommaso Croese – Simone Guerrieri – Giovanni Di Maggio – Stefania Medaglini – Lucia Moiola – Ubaldo Del Carro – Vittorio Martinelli – Roberto Furlan – Giancarlo Comi
Hospital San Raffaele, Department Of Neurology, Milan, Italy

Repair / Regeneration, Stem Cells and Neuroimmunomodulation

15 – Sera of relapsing-remitting multiple sclerosis patients express high levels of bone morphogenetic protein-2 that correlate with BMP-4 and BMP-5 levels, and induce low neuronal phenotype in P19 cells
Moran Penn (1) – Karin Mausner-Fainberg (2) – Maya Golan (2) – Arnon Karni (1) 
Neuroimmunology Laboratory, Department Of Neurology, Tel Aviv Sourasky Medical Center, Sackler’s Faculty Of Medicine, Tel Aviv University, Tel Aviv, Israel (1) – Neuroimmunology Laboratory, Department Of Neurology, Tel Aviv Sourasky Medical Center, Tel Aviv, Israel (2) 

17 – Human embryonic stem cell -derived oligodendrocyte progenitor cells provide long term immune-regulation and protection in a chronic-relapsing model of multuple sclerosis 
Yossi Nishri (1) – David Hampton (2) – Etti Ben-Shushan (3) – Benjamin E Reubinoff (3) – Siddharthan Chandran (2)Tamir Ben-Hur (1) 
Hadassah Hebrew University Medical Center, Dept. Of Neurology, Jerusalem, Israel (1) – University of Edinburgh, Division of Clinical Neurosciences, Edinburgh, United Kingdom (2) – Hadassah Hebrew University Medical Center, Human Embryonic Research Center, Jerusalem, Israel (3) 

20 – Investigating the role of astrocytes’ anti-excitotoxicity potential for neuronal damage formation in experimental autoimmune encephalomyelitis – an in vivo two-photon imaging approach 
Kamil S. Rosiewicz (1) – Tadhg Crowley (1) – Marlen Alisch (1) – Anca Margineanu (2)Volker Siffrin (1) 
Charité – Universitätsmedizin Berlin, Experimental And Clinical Research Center (ecrc) / Neuroimmunology Lab, Berlin, Germany (1) – Max Delbrück Center For Molecular (2) 

30 – Effect of fingolimod on neural stem cells: A novel mechanism and broadened application for neural repair 
Yuan Zhang (1) – Xing Li (1) – Bogoljub Ciric (1) – Cun-gen Ma (2) – Bruno Bran (3) – Abdolmohamad Rostami (1)Guang-Xian Zhang (1) 
Thomas Jefferson University, Thomas Jefferson University Hospital, Philadelphia, United States (1) – Shanxi Datong University, Medical School, Datong, China (2) – University Of Nottingham, School Of Medicine, Nottingham, United Kingdom (3) 

40 – Quantifying remyelination in vivo – metabolic labeling of myelin in an animal model of multiple sclerosis
Rina Aharoni – Chava Rozen – Elias Shezen – Dekel D. Bar Lev – Michael Sela – Ruth Arnon
The Weizmann Institute Of Science, University, Rehovot, Israel

68 – Prickle1 as positive regulator of oligodendrocyte differentiation
Rina Ilona Zilkha-Falb – Michael Gurevich – Erez Hanael – Anat Achiron
Sheba Medical Center, Center Of Multiple Sclerosis, Ramat-gan, Israel

81 – Possible role of microRNAs in the modulation of neuroinflammation by mesenchymal stem cells
Chiara Marini (1) – Benedetta Parodi (1) – Nicole Kerlero De Rosbo (1) – Marco Milanese (2) – Giambattista Bonanno (2) – Antonio Uccelli (1) – Debora Giunti (1) 
Neuroimmunology Unit, Department Of Neurosciences (dinogmi) – University Of Genoa, Genoa, Italy (1) – Pharmacology And Toxicology Unit, Department Of Pharmacy (difar) – University Of Genoa, Genoa, Italy (2) 

96 – Reparative macrophages that robustly promote remyelination: unexpected integration of pro-and anti-inflammatory triggers 
Manoj Mishra (1) – Khalil Rawji (1) – Michael B. Keough (1) – Yan Fan (1) – Reza Dowlatabadi (2) – Hans Vogel (2) – V. Wee Yong (1) 
Hotchkiss Brain Institute, University Of Calgary, Calgary, Canada (1) – Department Of Biological Sciences, University Of Calgary, Calgary, Canada (2) 

128 – iPSC-derived astrocytes are functional and respond to multiple sclerosis-relevant cytokines stimulation 
Sylvain Perriot (1) – Guillaume Perriard (1) – Amandine Mathias (1) – Mathieu Canales (1) – Nicole Déglon (2) – Renaud Du Pasquier (3) 
Chuv, Laboratory Of Neuroimmunology, Department Of Clinical Neurosciences, Lausanne, Switzerland (1) – Chuv, Laboratory Of Cellular And Molecular Neurotherapies, Department Of Clinical Neurosciences, Lausanne, Switzerland (3) – Chuv, Laboratory Of Neuroimmunology, Service Of Neurology, Department Of Clinical Neurosciences,, Lausanne, Switzerland (3) 

151 – Neural stem cells show differential viability and distribution upon intrathecal transplantation in the acute and chronic phases of experimental autoimmune encephalomyelitis 
Arianna Merlini (1) – Donatella De Feo (1) – Francesca Ruffini (1) – Giancarlo Comi (2) – Gianvito Martino (1) 
San Raffaele Scientific Institute, Neuroimmunology Unit -institute Of Experimental Neurology, Milan, Italy (1) – San Raffaele Scientific Institute, Neurology Department -institute Of Experimental Neurology, Milan, Italy (2) 

155 – Neuralized Mesenchymal Stem Cells: A novel cellular Therapy Paradigm for the treatment of Multiple Sclerosis
Ibrahim Kassis – Moriel Ben-Zwi – Panayiota Petrou – Michelle Halime – Dimitrios Karussis
Department of Neurology and Agnes-Ginges Center for Neurogenetics , Hadassah-Hebrew University Medical Center, Jerusalem, Israel

164 – Isolation of recombinant IgG Fab fragments recognizing neural precursor stem cell antigens using the antibody phage display technique
Ioannis Paspaltsis (1) – Evangelia Kesidou (2) – Eva Nousiopoulou (2) – Olga Touloumi (2) – Roza Lagoudaki (2) – Theodoros Sklaviadis (1)Nikolaos Grigoriadis (2) 
Aristotle University Of Thessaloniki, Prion Diseases Research Group, School Of Pharmacy, Thessaloniki, Greece (1) – Aristotle University Of Thessaloniki, Laboratory Of Experimental Neurology And Neuroimmunology, Thessaloniki, Greece (2) 

171 – MIS416, a myeloid-targeted immune modulator for the treatment of neuro-inflammatory based disorders, enhances functional recovery in a spinal cord injury model 
Masoud Hassanpour Golakani (1) – Manvendra Saxena (1) – Hui Li (1) – David Brown (1)Gill Webster (2) 
Laboratory Of Neuroinflammation, St Vincent’s Centre For Applied Medical Research, University Of New South Wales, Sydney, Australia (1) – Innate Immunotherapeutics, Auckland, New Zealand (2) 

221 – Antigen specific therapy in Multiple Sclerosis and Neuromyelitis optica: a phase 1b clinical trial with tolerogenic dendritic cells 
Irati Zubizarreta (1) – Georgina Florez (2) – Gemma Vila (1) – Raquel Cabezon (2) – Carolina España (2) – Daniel Benitez-Ribas (2) – Sara Varea (3) – Joan Albert Arnaiz (3) – Albert Saiz (4) – Pablo Villoslada (1) 
Institut d’investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Hospital Clinic I Provincial / Universitat De Barcelona / Neurology, Barcelona, Spain (1) – Centro De Investigación Biomédica En Red De Enfermedades Hepáticas Y Digestivas (ciberehd), Hospital Clínic I Provincial And Centre Esther Koplowitz / Universitat De Barcelona, Barcelona, Spain (2) – Clinical Trials Unit (ctu), Hospital Clinic Provincial / Universitat De Barcelona / Clinical Pharmacology Service, Barcelona, Spain (3) – Center Of Neuroimmunology And Department Of Neurology, Hospital Clinic I Provincial / Universitat De Barcelona / Neurology, Barcelona, Spain (4) 

239 – Lipid metabolism modulates the immunomodulatory properties of Mesenchymal Stem Cells 
Laura Lovato (1) – Natalia Realini (2) – Daniele Piomelli (3) – Antonio Uccelli (4) – Francesco De Angelis (1) 
Italian Institute Of Technology, Department Of Plasmon Nanotechnologies, Genoa, Italy (1) – Italian Institute Of Technology, Department Of D3 Validation, Genoa, Italy (2) – University Of California, Department Of Anatomy & Neurobiology, Irvine, United States (3) – University Of Genoa, Department Of Neurosciences, Genoa, Italy (4) 

248 – Oncostatin M signaling is essential for robust remyelination 
Kris Janssens (1) – Evelien Houben (1) – Anurag Maheshwari (1) – Chris Van Den Haute (2) – Tom Struys (1) – Ivo Lambrichts (1) – Veerle Baekelandt (2) – Piet Stinissen (1) – Jerome Hendriks (1) – Helena Slaets (1)Niels Hellings (1) 
Hasselt University, Biomedical Research Institute, Diepenbeek, Belgium (1) – Kuleuven, Department Of Neuroscience, Laboratory For Neurobiology And Gene Therapy, Leuven, Belgium (2) 

253 – Neural precursor cell-secreted factors twist the inflammatory program of CNS- invading monocyte-derived dendritic cells in experimental multiple sclerosis 
Donatella De Feo (1) – Arianna Merlini (1) – Elena Brambilla (1) – Linda Ottoboni (1) – Cecilia Laterza (1) – Giancarlo Comi (1) – Cinthia Farina (1) – Melanie Greter (2) – Gianvito Martino (1) 
Insitute Of Experimental Neurology, San Raffaele Scientific Institute, Milano, Italy (1) – Institute Of Experimental Immunology, University Of Zurich, Zurich, Switzerland (2) 

281 – Phase II double blind trial to investigate the efficacy and the Optimal Way of Administration (based on the clinical, neurophysiological and neuroradiological effects) of Autologous Mesenchymal Bone M 
Panayiota Petrou – Ibrahim Kassis – Neta Levin – Michelle Halimi – Tamir Ben Hur – Adi Vaknin – Ariel Ginsberg – Dimitrios Karussis
Neuroimmunology And Cell Therapy Unit, Department Of Neurology, Hadassah Hebrew University Medical Center, Jerusalem, Israel 

292 – Endogenous neural stem cells regulate striatal homeostasis 
Erica Butti (1) – Marco Bacigaluppi (1) – Elena Brambilla (1) – Stefano Taverna (1) – Veronica Bianchi (2) – Patrizia D’Adamo (2) – Marco Cambiaghi (3) – Mathias Hoehn (4) – Gianvito Martino (1) 
Neuroimmunology Unit, Division Of Neuroscience, Inspe, San Raffaele Hospital, Milan, Italy (1) – Molecular Genetics Of Mental Retardation, Division Of Neuroscience, San Raffaele Hospital, Milan, Italy (2) – Laboratory Of Behavioral Neurophysiology, Department Of Neuroscience “rita Levi-montalcini”, University Of Turin, Turin, Italy (3) – In-vivo-nmr Laboratory, Max Planck Institute For Metabolism Research, Cologne, Germany (4) 

322 – Human iPSC-derived neurons from multiple sclerosis patients as a tool to assess cell specific dis-functions and pharmacological drug effects 
Linda Ottoboni (1) – Cecilia Laterza (2) – Francesca Ruffini (1) – Mario Barilani (1) – Simona Baronchelli (4) – Rosa Bonaccorso (1) – Ida Biunno (4) – Lorenza Lazzari (3) – Stefano Taverna (1) – Gianvito Martino (1) 
Neuroimmunology, San Raffaele Hospital, Milan, Italy (1) – Lund Stem Cell Center, Lund University, Lund, Sweden (2) – Fondazione Ircss Ca’ Granada, Ospedale Maggiore Policlinico, Milan, Italy (3) – Irgb, Cnr, Milan, Italy (4) 

356 – Treatment of Experimental Autoimmune Encephalomyelitis with Mixed Chimerism and Concurrent Neural Stem Cell Transplant 

William Orent – Jose Marino – Joshua Paster – Gilles Benichou – David H. Sachs
Harvard Medical School, Center For Transplantation Sciences – Massachusetts General Hospital, Boston, United States

365 – RGMa regulates T cell responses and neurodegeneration in autoimmune encephalomyelitis
Toshihide Yamashita
Graduate School Of Medicine, Osaka University, Department Of Molecular Neuroscience, Suita-shi, Japan

Pediatric MS

274: Towards an improved classification of relapsing demyelinating syndromes of the central nervous system in children
Yael Hacohen (1) – Kshitij Mankad (2) – W. Kling Chong (2) – Frederik Barkhof (3) – Ming Lim (4) – Evangeline Wassmer (5) – Olga Ciccarelli (6) – Cheryl Hemingway (1) 
Great Ormond Street Hospital For Children, Department Of Paediatric Neurology, London, United Kingdom (1) – Paediatric Neuroradiology,, Great Ormond Street Hospital For Children Hospital, London, United Kingdom (2) – Institutes Of Neurology And Biomedical Engineering, Ucl, London, United Kingdom (3) – Children’s Neurosciences, Evelina Children’s Hospital, Guy’s And St Thomas’ Nhs Foundation Trust, King’s Health Partners Academic Health Science C, London, United Kingdom (4) – Department Of Paediatric Neurology,, Birmingham Children’s Hospital, Birmingham, United Kingdom (5) – Department Of Neuroinflammation, Queen Square Ms Centre, Ucl Institute Of Neurology, London, United Kingdom (6) 

364 – Preconditioned MSCs treat myasthenia gravis in a humanized preclinical model 
Muriel Sudres (1) – Marie Maurer (1) – Marieke Robinet (1) – Jacky Bismuth (1) – Frédérique Truffault (1) – Nadine Dragin (1) – Elie Fadel (2) – Nicola Santelmo (3) – Camille Sicsic (4) – Talma Brenner (4)Sonia Berrih-Aknin (1) 
Center of Research in Myology, Sorbonne Universités, UPMC, INSERM U974,CNRS FRE 3617, Institute of Myology, Paris, France (1) – Centre Chirurgical Marie Lannelongue, Le Plessis Robinson, France (2) – Hôpital Civil de Strasbourg, Strasbourg, France (3) – Department of Neurology, Hadassah Hebrew University Medical Center, Jerusalem, Israel (4) 

374 – Cognitive impairment in children and adolescents with multiple sclerosis
Shay Menascu – Royi Aloni – Anat Achiron
Multiple Sclerosis Center, Sheba Medical Centre Tel HaShomer, Israel